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Abstract
Chinese and Indian cultures consider their ancient herbal texts valuable
resources in the search for novel compounds with potential pharmacological
applications. However, despite a rich history of medicinal plant use throughout
the British Isles, much of the native flora recorded in the Anglo-Saxon medical
texts (the Herbarium, Bald’s Leechbook and the Lacnunga) studied here has yet
to be evaluated. A model was developed for bio-screening medicinal plants
using <30 g of dried material for bioassay and structure elucidation. In this
study, six native species were screened using a 96-well microdilution bioassay
(200, 40 and 8 µg/mL) against representative strains of Gram-positive and
Gram-negative pathogens commonly found in wounds. All plants exhibited
activity against Gram-positive organisms in one or more leaf extracts (MIC50
200 µg/mL). Of the 8 extracts per plant, the 25% and 75% EtOH root extracts
of Agrimonia eupatoria L. and Potentilla reptans L. were effective against S.
aureus at the lower concentration (MIC50 8 µg/mL) and inhibited growth of
Gram-negative pathogen E. coli (MIC50 40 µg/mL). P. reptans was selected for
further investigation on the basis of its activity against E. coli and underreported
phytochemistry compared to A. eupatoria. In the MIC assay the 75% EtOH root
extract of P. reptans demonstrated the widest range of activity against S.
aureus (MIC50 31.25 – full MIC of 1000 µg/mL). The P. reptans root decoction
was the most potent extract against E. coli (MIC50 3.9 µg/mL) and comparable
to chloramphenicol, a broad spectrum antibiotic. Principal components analysis
(PCA) when overlaid with antimicrobial activity, directed the optimisation of the
HPLC and LC-MS methods. Seven antimicrobial compounds were putatively
identified for P. reptans (agrimonolide-6-O-glucopyranoside, chlorogenic acid,
ellagic acid, epicatechin, procyanidin B, procyanidin C, and tormentic acid).
This study has shown some native species in the Anglo-Saxon formulations
may have been effective for treating bacterial infection in wounds and that the
medical texts are a valuable source for rediscovering plants and medicinal uses
lost to Western herbal practice.
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Chapter1.0 Anglo-Saxon Medical Literature
The pharmaceutical search for novel plant compounds has predominantly
focussed on countries where the flora is highly specialised to its specific
environment and mainly undiscovered, increasing the potential of finding
something new and reducing the likelihood of competitors researching the same
material (Schmidt et al., 2007). The British Isles shares a common biodiversity
of plants with Europe, covering a relatively large land mass and consequently;
native species have been neglected in the search for novel compounds with
potential pharmacological applications. Chinese and Indian cultures consider
their ancient medicinal texts to be valuable sources for drug discovery whereas
in Britain, Anglo-Saxon medical texts have been under-researched. New
translations now provide greater access to the early medieval literature for
scientific investigation of medicinal formulations used in this Western herbal
tradition (Watkins et al., 2011). Western herbal medicine (WHM) is a recent
term to describe the use of medicinal plants mainly native to Europe within
herbal practice grounded in local tradition (Nissen and Evans, 2012).
1.1 Anglo-Saxon England (499-1066)
Following the departure of the Romans from England, the Anglo-Saxons faced
many battles with the Vikings and by 10th century settlements had formed
around monastic sites and sea ports (Fig. 1.1). King Alfred is believed to have
commissioned the Anglo-Saxon chronicle to document major battles, events
and natural phenomenon from the birth of Christ; a tradition that was continued
into the 12th century (Whitelock et al., 1961). When Alfred came to rule (871-99)
there was a distinct lack of literacy in the land. He pioneered an educational
renaissance by bringing scholars from overseas and setting up a palace school
although by the 10th century, the remit of education had returned to the
monasteries (Lapidge et al., 2001). The surviving 10th century medical texts are
important medical records in that they were written in the vernacular; a unique
practice not seen elsewhere in Europe during this period (Meaney, 2000;
Payne, 1904).
1 
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1.1.1Lifestyle and Disease
Battle wounds, amputations and burns were common place and eye, skin and
urinary problems consistently feature in the medical texts suggesting deficiency
in vitamin A during the winter months and also vitamin C would have resulted in
bleeding gums, scurvy, ulcers and dysentery (Cayton, 1977; Hagen, 2006).
Disease encompassed plague and leprosy; viral infections or ‘flying venoms’
and a variety of parasites, especially ‘burrowing worms’ (Cameron, 2006; Hart
2003). Illness was viewed as a range of symptoms creating an imbalance within
the body and the prescribed medication having the capacity to warm or cool the
body in order for the patient to regain a balance of health based on classical
texts, observations and therapeutics (Meaney, 1991). The Anglo-Saxon
aristocracy ate fresh meat and fish in spring/summer and salted food during
winter. For the poor, the diet comprised mainly grain, of barley and wheat to
provide bread and leafy vegetables and nuts when in season. The monastic
communities had a varied diet and monks were taught signs so as to request
food during periods of silence (Banham, 2002; Hagen, 2006).
 
 
Fig. 1.1 The English Kingdoms during 10th century (Lapidge et al., 2001).
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1.1.2The Anglo-Saxon Practitioner (Laece) or Medic
For more than half a millennium battles, disease, droughts and famines in
Anglo-Saxon England created great demands upon human health and the
physicians attending the wounded and the sick. Evidence suggests multiple
layers of medical practice: learned physicians or medics to attend the royal
household; physicians without tonsure depicted in illustrated manuscripts in
addition to practicing members of the clergy and monastic orders (Hart, 2003;
Meaney, 2000) as well as folklore plant knowledge transferred by oral tradition
(Allen and Hatfield, 2004). This structure of medical practice was evident in the
time of Dioscorides during the 1st century and is often seen in indigenous
cultures around the world (Riddle, 2011).
There are only seven medics or practitioners named in the Anglo-Saxon
literature. Oxa and Dun are two named physicians in Bald’s Leechbook
although very little is known about the teaching of herbal practices at this time
(Banham, 2002; Cockayne, 1865). The surviving Anglo-Saxon medical texts
were part of a wider body of literature available to the Anglo-Saxon practitioner
as in ‘some books teach for the half dead disease...’ (Cockayne, 1865, p.285).
Practitioners were able to call upon Greek and Latin texts to prescribe herbal
exotics for the rich that could afford to pay high prices whilst using common
plants for the poor (Talbot, 1967). London was a vibrant trade centre
exchanging goods with Europe, Africa and the East and exotic spices were
highly valued (Hagen, 2006). The Anglo-Saxon practitioner would have required
a prior knowledge of plants and herbal practices to be confident in his ability to
treat disease and charge for services. As early as the 7th century Anglo-Saxon
law established that should a person be injured as a result of another the
perpetrator would incur the laecefoh or ‘doctors fee’ (Meaney, 2000; Pollington,
2008; Rubin, 1970).
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1.2Anglo-Saxon Medical Texts
Three of the four major early medieval texts reporting herbal formulations from
10th century England, the Herbarium, Bald’s Leechbook and the Lacnunga, may
contain insights into medicinal uses of native species yet to be evaluated
(Watkins et al., 2011). These texts were compiled for medicinal use and
demonstrate the breadth of medical knowledge available to those able to read
in the vernacular. The compilers of the original texts were experts with a good
understanding of plant names, medicinal applications and multiple languages.
Bilingual glosses dedicated to plant names in Latin/Old English such as in the
Durham Herbal Glossary and Laud Herbal Glossary were both in circulation in
the early medieval period (D’Aronco and Cameron, 1998). There is also
evidence of foreign texts being exchanged between monastic houses as
physicians travelled across Europe, Africa and the Middle East (Voigts, 1979).
Access to these texts was limited to readers of Old English until the 19th century
when philologist Thomas Oswald Cockayne of Kings’ College London, was
commissioned by the British government to translate all of the known medical
Anglo-Saxon manuscripts into modern English.
1.2.1 Modern English Translations
Cockayne’s translation of 1864-6 is to date, the only complete English edition
albeit other authors have produced more recent translations of individual texts
(Cameron, 2006; Meaney, 1984, Van Arsdall, 2002). The harsh views of
Charles Singer and his student, Wilfred Bonser in the middle of the last century,
did much to undermine the value of the Anglo-Saxon medical literature. Bonser,
said they were ‘sterile formulas, which could be applied without any exercise of
reasoning, alone survived for use during the Dark Ages’ (Cameron, 2006;
Talbot, 1967; Voigts, 1979). Around fifty years ago Anglo-Saxon historians and
linguists redefined the contextual position for the original manuscripts and
modern translations followed for the Herbarium, Bald’s Leechbook III and the
Lacnunga. (Cameron, 1982; Meaney, 2000; Pettit, 2001, Pollington, 2008; Van
Arsdall, 2002). Today, over five hundred leaves of medical manuscripts,
compiled in Old English, survive in national and private collections. Of these,
three major works (Table 1.1) were compiled by physicians for physicians,
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describe herbal formulations for common conditions affecting human and
animal health in England during 10th century (Cameron, 2006; Meaney, 2000;
Voigts, 1979).
1.2.2 The Herbarium
The Old English translations of Pseudo-Apuleius, Pseudo-Dioscorides De
Herbis Femininis and the Curae Herbarium are today jointly referred to as the
Herbarium. The only surviving illustrated herbal from the 10th century (British
Library: Cotton Vitellius C.iii) was compiled from an earlier Latin herbal (4-5th
century) demonstrating this was an important medical text, possibly in general
circulation for physicians (Meaney, 2000; Van Arsdall, 2002; Voigts, 1979). The
author of this text edited and reordered the Latin literature and was selective in
the final content in retaining only 29 of the 47 original formulations for Betonica
officinalis (Voigts, 1979). The Herbarium lists a number of herbal formulations
for each plant and for some native species specified the habitat and time of
harvesting suggesting the Anglo- Saxon practitioner used an empirical
approach to plant collection (Cockayne, 1864; Van Arsdall, 2002). The Old
English Herbarium included a table of contents not seen in the Latin originals
and with numerous annotations in the margins, illustrate it was designed for use
as a working herbal with 101 of the 185 plants found in Bald’s Leechbook
(D’Aronco and Cameron, 1998).
1.2.3 Bald’s Leechbook
The copy of Bald’s Leechbook (British Library: Royal 12, D. xvii) is a unique text
written in the middle of the 10th century believed to be from an earlier copy
commissioned by King Alfred in the late 9th century. This gold standard literature
assimilates the best of medical knowledge written in the vernacular for use by
physicians to attend the royal household (Banham, 2011; Meaney, 2000;
Voigts, 1979). The owner of the book, Bald, is mentioned in the preface and
Cild as his scribe although it is not known if Bald was a physician and/or monk.
Bald’s Leechbook is a collection of two volumes carefully ordered by conditions
starting at the head and moving down to the toes. The former is concerned with
mainly external complaints and the second devoted to internal ailments. The
second volume includes lengthy discussions on varying aspects of health that
Chapter 1 – Anglo-Saxon Medical Literature 
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Fig. 1.2 Plate IV featuring Wagbraede (Plantago major L.) in the Old English Illustrated
copy of the Herbarium (D’Aronco and Cameron, 1998). © British Library, Cotton
Vitellius C. iii, folio 21v (with permission of the British Library and publishers Rosenkilde
& Bagger).
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demonstrate an understanding of body functions including the liver
(Cockayne,1865; Cayton, 1977; Pollington, 2008). There is a reference to the
quality of practitioners ‘unwise leeches ween, that is loin disease, or milt wark:
but it is not so...’ (Cockayne, 1865, p.233) suggesting Bald’s Leechbook was
the authority on such matters. A third volume referred to as Leechbook III is
considered to be older in origin than the other two volumes with less of a
Mediterranean influence with less bloodletting and cautery and more
miscellaneous incantations/ prayers (Cameron, 2006; Meaney, 2011;
Pollington, 2008).
1.2.4The Lacnunga
A lesser known semi-complete collection of 193 leaves commonly referred to as
the Lacnunga (British Library, MS Harley 585) is thought to have been compiled
by a practitioner for use by a practitioner although the owner and scribe are
unknown. The collection includes a number of remedies from all three volumes
of Bald’s Leechbook and is therefore considered of a later date although it does
not include a contents list. The collection is of a lesser quality compared to
Bald’s Leechbook and derived from a text that no longer survives. A number of
folios have scribal corrections in different hands, illustrating that the texts were
used and updated over time (Cockayne, 1864; Meaney, 2000; Pettit, 2001).
This transfer of knowledge by copying and amending of formulations has been
common practice throughout history and a large number of Old English
formulae are known to have been in circulation prior to 9th century (Cameron,
1982; Meaney, 1991).
1.2.5 Botanical Identification of the Anglo-Saxon plants
The identification of plants in the texts has caused much debate. Ambiguity
does arise where the Anglo-Saxons used a collective name for different species
as in docce or dock for a group of plants with similar medicinal actions so we
cannot know precisely which plant was being referred to in the formulae
(Banham, 2002; Cameron, 2006, Pollington, 2008). A study of plant names
from medieval manuscripts (Hunt, 1989) revealed more than 1800 vernacular
names covering over 600 plant species demonstrating the difficulty in correctly
assigning plant names. There is further confusion regarding some entries in the
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Herbarium whereby the accompanying illustrations refer to a subsequent
remedy or may be an incorrect translation of the original text (Cameron, 2006;
Meaney, 2000; Voigts, 1979). Charles Singer believed the plant illustrations to
be of no use and not a true likeness to the actual species, although Van Arsdall
(2002) argues that the stylised illustrations depict dried specimens that would
have been useful to a practitioner working with plants (Fig. 1.2). A number of
entries have a definite space left for the synonym to be inserted as in ‘for a
swollen stomach, take the seeds of this plant which is called nymfeta or ... (Van
Arsdall, 2002, p.179) indicating that the scribe was unfamiliar with the plant in
question and/or had other sources to consult (Cockayne, 1865, Van Arsdall,
2002). Plants mentioned in the Anglo-Saxon medical literature now known to
have therapeutic properties and used in drug development have been described
previously (Watkins et al., 2011).
Medicinal plants could have been identified from a number of sources: in
both Bald’s Leechbook and the Lacnunga the plant names are predominantly
Old English (Pettit, 2001). By contrast the illustrated copy of the Herbarium
gives a stylised colour drawing for each plant along with a Greek or Latin name
and a list of synonymies at the end of each entry including Gaulish, Etruscan,
Dacian, Spanish, African and Syrian plant names ending with an Anglo-Saxon
synonym if known (D’Aronco and Cameron, 1998; Meaney, 2000); a practice
also found in early works of Dioscorides (Hunt, 1989; Riddle, 2011).
1.2.6 Anglo-Saxon Herbal Formulations
The classical Latin texts comprised of mainly simples whilst Bald’s Leechbook
and the Lacnunga contain a combination of simple and complex mixtures
perhaps demonstrating an evolutionary pattern of ethnomedica as in Traditional
Chinese Medicine literature, arguably one of the oldest documented herbal
traditions (Riddle, 2011). D’Aronco and Cameron (1998) state that >130 plant
names in the illustrated Herbarium are to be found in modern Western herbal
pharmacopoeias; for example Centaurium erythraea Rafn. and Marrubium
vulgare L. both continue to be used in WHM (Barker, 2001; Tobyn et al., 2011;
Williamson, 2003). Bald’s Leechbook and the Lacnunga include >20 native
British tree species not referenced in the Herbarium and utilise a larger materia
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medica with >250 medicinal plants that are also evident in the earlier pre
Christian Leechbook III (Cockayne, 1865; Pettit, 2001).
Bald’s Leechbook is an example of an improved text that has incorporated five
formulae from the earlier Leechbook III and similarly there are several formulae
in the later collection of Lacnunga that also appear in Bald’s Leechbook
(Meaney, 1991). The copying and amending of formulations is evident in later
16th and 17th century European herbals (Adams et al., 2009), ‘Culpeper’s
Complete Herbal for the English Physician’ (1653) and more recently, ‘A
Modern Herbal’ (Grieve, 1931), all containing formulations similar to those in the
Anglo-Saxon medical texts although the source is rarely attributed. Early
medieval medical treatment was empirical, pragmatic and sometimes effective
using imbalance as an explanation of illness (Cameron, 2006; Meaney, 1991;
Payne, 1904). Betony or B. officinalis L. is the most frequently cited plant in all
of the medical texts and whilst the Anglo-Saxon scribe reduced the number of
entries from 47 in the Latin copy to 29 in the Herbarium; it is still the largest
number of formulae allocated to a single plant in the Old English medical
literature (Cayton, 1977; Van Arsdall, 2002; Voigts, 1979).
In Bald’s Leechbook, the reader is encouraged to observe the patient
and apply a greater or lesser amount of the formulation according to the
constitution of the man, woman or child (Cockayne, 1865, p.85). Herbal
formulae comprised ‘simples’ or single plant remedies as well as complex
mixtures (Table 1.2) as herb drinks, creams, salves and poultices at the heart of
this medical practice (Crawford, 2010). The whole plant or specified parts
including leaves, flowers, roots, seeds and juice were prepared as infusions and
decoctions, classified as ‘wort’ or ‘spewit’ drinks for internal consumption;
applied topically pounded or mixed in animal grease for ointments and salves or
mixed with grain and binded on as a poultice. Bald’s Leechbook states that
inflamed injuries from wounds, cuttings or blows were to be debrided and a
barley poultice applied ‘in the manner that leeches well know’ and foul wounds
to be cleaned using honey and salt mixed in a clean vessel and shaken until the
consistency of a herb drink (Cockayne, 1865, p.83). For burns, salves from
grease or butter were applied with one formula recommending the frequent
application of an egg white to the wound (p.131). Crawford (2010) believes both
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Table 1.2 Vehicles used in 10th century Anglo-Saxon formulations.
   Type of 
Formulation 
Vehicles Example Formulation 
Herbal Drinks 
comprising 
'brewits' and 
'spewits' 
Water, ale, wine, 
milk 
‘A wound drink: pound small the netherward 
and upward part of ribwort, carline thistle, and 
the netherward part of ashthroat, put them in 
boiling water, rub between the hand and strain 
through a cloth, administer to drink',  
(Balds Leechbook,  xxxviii)
a 
 
 
Washes for 
cleaning 
wounds 
Water, honey, 
vinegar 
‘If a cancer sore grows on a wound, take the 
plant, boil it gently in water, and bathe the 
wound with it. Then take the plant, soap and 
grease; pound them in vinegar. Put this on a 
cloth and lay it on the wound', (Herbarium,  37)
c 
 
 
Salves Butter, old pig 
grease, chicken and 
fox grease, honey 
‘If a man be smitten with wood or with stone, or 
if a boil bursteth on a man, for this a sound 
salve: cockle, 'ontre', silverweed, turnsole, 
pound the worts thoroughly, mingle well with 
butter, and prepare in the same way which 
before I quoth' , (Balds Leechbook, xxxviii)
a 
 
 
Poultices 
 
Bread, old pig 
grease, barley, bean, 
oat 
‘If any part of the body becomes stiff, take the 
plant that is called lapatium or dock, some aged 
pig's grease and crumbs from oven-baked 
bread. Pound this together in the manner you 
would make a poultice, lay it on the sore place, 
and it helps wonderfully', (Herbarium,  34)
c 
 
‘For the great oozing foot disease, which 
doctors call podagra. Take groundsel, that 
which grows in buildings, and the red wudufille, 
an equal amount of both; pound with the old fat 
of a pig; make it into a poultice’, (Lacnunga, 
CXX)
b 
 
Steam Baths Water Following preparation of body salve, ‘A bath for 
blotch, boil ten times the worts in a basin and 
separately ... of all equally much ...  pour the 
prepared hot liquor under the stool in the 
bucket, let it reek on thee...’, (Balds Leechbook,  
xxxii)
a 
 
Cockayne (1865)
a
,  Pettit (2001)
b  
and
 
Van Arsdall (2002)
c
. The references at the end of 
each entry detail the medical text and the numbered entry given by the translator.  
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Bald and Cild, owner and scribe respectively of the Leechbook, had
sufficient knowledge of medicinal plants to consciously decide only to
include weights and measures where different to the accepted preparatory
method. There may have been other books for instruction in preparation of
the different formulations and if so, with so little of the herbal literature
surviving from this era, are now lost. D’Aronco (2007) makes the comment
that three of the pre Anglo-Norman copies of Herbarium use capital letters
for the beginning of a new chapter as well as a new remedy (p.44).
Cockayne (1865) in his translation of Bald’s Leechbook, follows the original
text and repeats the frequent instructions of ‘again’ and ‘for the same’ in a
single formulation although does not discuss the illuminated letters that also
appear in the Lacnunga (Fig. 1.3). Pettit (2001) describes this collection of 
Fig. 1.3 Decorated initials in Balds Leechbook. © British Library (Royal 12 D. xvii, folios
20v-21).
letters as zoomorphic initials in the form of snakes, serpents and dragons or
simple decorated initials used as guide letters. To date, these initials have not
been considered an integral part of the formulation, perhaps defining the type of
preparation. Knowing how the medication was prepared and administered
would enhance current understanding of the value of historical texts in
Chapter 1 – Anglo-Saxon Medical Literature 
13 
 
ethnopharmacology. A coded formula would have provided the practitioner with
a system to quickly recall a formulation and at the same time, prevent persons
without herbal knowledge from dispensing remedies.
1.3 Battle Wounds and Injuries
Battle wounds, animal bites and burns were commonplace in Anglo-Saxon
England with amputation recognised as a necessary procedure for wounds
infected with gangrene (Cockayne, 1865; Van Arsdall, 2002). In the early
medieval period, mortality rates on the battlefield were reported to be 42% from
arrows, 67% sling shots and 100% from sword injuries (Hutley and Green,
2009). War wounds contaminated by soil borne organisms would have resulted
in discharging pus, deformed scarring and slow healing as well as exposing
individuals to potential bloody viruses. Seasonal and environmental variation in
bacteria would have meant more faecal pathogens in summer, for example,
Enterococcus faecalis and a greater presence of Staphylococci and
Streptococci during the winter. Aerobic organisms commonly associated with
wound infection include Streptococcus pyogenes, Staphylococcus aureus,
Escherichia coli and Pseudomonas aeruginosa (Collier, 2004). In the laboratory,
a standard in vitro antimicrobial assay is based on four common wound
organisms to determine whether the plant extract or compound is able to inhibit
growth of Gram-positive and Gram-negative bacteria (Quave et al., 2008;
Kumarasamy et al., 2003). The microdilution method (NCCLS, 2009) will
provide an initial screening process to determine activity for the selected plants
and ascertain whether they would have been appropriate in treating bacterial
infection and wounds.
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1.4 Scope of Research
This research is grounded in a 2008 UEL BSc (Hons) Herbal Medicine
dissertation that compares and contrasts modern clinical use of plants named in
Anglo-Saxon herbal formulations and subsequently an article was published in
Journal of Herbal Medicine (Thomas, 2011). The proposed objectives herein
are to:
• Review the 10th century Anglo-Saxon medical literature concerning the
use of medicinal plants in herbal wound healing formulations.
• Design a selection model for conducting an in vitro bioassay of native
British plants used specifically to treat bacterial infection and wounds (a
reasonably large number of species were selected in order to minimise
the risk of not finding any antimicrobial activity).
• Evaluate the bioactivity and phytochemistry of selected plants using
chemometric techniques.
• Identify the active metabolites from the most potent plant.
An outline of the project plan is shown in Fig. 1.4.
Chapter 1 – Anglo-Saxon Medical Literature 
15 
 
Plant Collection
Initial 
Antimicrobial 
screen
IC50
Plant Selection 
Methodology and 
Dereplication
In vitro 
Antimicrobial 
Assay 
MIC/MBC
HPLC 
Compound 
Screen
Principal 
Components 
Analysis
Define 
Active 
Compounds
HR-ESI-MS
Plant Extractions
Using H2O, EtOH 
and Red wine
Literature Review
Fig. 1.4 Project plan to determine the antimicrobial activity of six native British
plants used in 10th century Anglo-Saxon wound healing formulations.
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Chapter 2.0 Plant Selection Strategy
2.1 Introduction
Despite a rich history of medicinal plant use throughout the British Isles, much
of the native flora listed in the Anglo-Saxon medical literature has yet to be
evaluated for its pharmacological and medicinal applications (Watkins et al.,
2011). However, many of the underresearched medicinal plants have a long
tradition of being used in Western herbal medicine (WHM) to treat bacterial
infections and wounds (Culpeper, 1653; Grieve, 1931; Tobyn et al., 2011).
Forbes (2003) defines a native species as a plant that arrived in the British Isles
before the beginning of Neolithic farming (around 4000 BC) or since,
independently of human association. A modern authority on British flora used by
the Botanical Society of the British Isles (BSBI) for the identification of wild
vascular plants is the New flora of the British Isles (Stace, 2010). Stace
classifies a native species as a plant that colonised the British Isles by natural
means from other native areas and an archaeophyte, as a plant mainly
associated with man’s activities present in the British Isles since at least
medieval times.
Willow Salix alba L. and poppy, Papaver somniferum L. provided the
chemical architecture for the synthetic production of aspirin and morphine
respectively (Riddle, 1974). Both species are classified by Stace as
archeophytes and are found in a number of Anglo-Saxon herbal preparations.
One Leechbook formulation states ‘For spleen pain pound green willow bark,
boil it alone in honey, give it to him to eat, three pieces, having fasted overnight’
(Pollington, 2008, p.387). A formula for popig or poppy in the Herbarium says
‘For sleeplessness, take the juice of the same plant, rub it on the person and
you will quickly give him sleep’ (Van Arsdall, 2002, p.174). Arguably, one of the
greatest contributions to drug discovery has been the alkaloid group with
codeine and morphine isolated from P. sominferum as a result of scientific
investigation of folklore traditions (Holland, 1996).
Previous pharmacological studies of native plants listed in the Anglo-
Saxon medical texts suggested that some were effective and led to the
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identification and isolation of natural compounds. Matricin from yarrow Achillea
millefolium L. is a proprionic acid analogue that yields chamazulene carboxylic
acid with cyclooxygenase-2- activity similar to that of ibuprofen (Watkins et al,
2011). The Anglo-Saxon practitioner employed many native species in his
pharmacopoeia as well as exotic imports that would have been purchased via
one of the many trading ports at London or along the English coast (Cameron,
2006; Hagen, 2006). St John’s wort Hypericum perforatum L. is a native species
that has been well studied for its pharmacological actions with hyperforin
identified as the main metabolite responsible for its antibacterial properties
(Saddiqe et al., 2010). However, in the Herbarium the plant is considered for
different complaints ‘pounded and drunk this plant stimulates urination... for a
quartan fever, take the same plant, pounded , and give it to drink in wine’ (Van
Arsdall, 2002, p.216). A quatern fever is a type of malaria and according to
Pollington (2008) H. perforatum had a reputation for purifying and strengthening
other herbal formulations. Another native species, white horehound Marrubium
vulgare L. is listed in all three of the Anglo-Saxon herbal texts for treating
coughs, colds, snakebites and poisonings; a common occurrence with people
collecting wild foods from the hedgerows (Hagen, 2006). One remedy for cough
in Bald’s Leechbook III specifies ‘for host or cough; boil marrubium in water, a
good deal of it, sweeten a little, give the man to drink a cup full’ (Cockayne,
1865, p.313). Today, the plant in WHM is prescribed as a recommended daily
adult dose equivalent to 3-6 g herb, primarily for treating bronchitis and asthma
(Williamson, 2003). Marrubium vulgare has demonstrated antimicrobial activity
against methicillin-resistant Staphylococcus aureus (MRSA) with an EtOH root
extract reducing adherence of biofilms ranging from a MIC50 value of 8 µg\mL
to a MIC90 value of 128 µg\mL (Quave et al., 2008). Another native species
exhibiting antimicrobial activity is the hop Humulus lupus L. derived from the
Anglo-Saxon hoppan meaning to climb. Humulone and lupulone isolated from
hops have been attributed to the antibacterial activity against Staphylococcus
species with MIC values of 6.25 µg/mL and 3.13 µg/mL respectively (Zanoli and
Zavatti, 2008). Ivy Hedera helix L. is an important herb in WHM, particularly in
Germany, for treating respiratory conditions and, although native, is no longer
used medicinally in Britain. The effectiveness of H. helix has been
demonstrated in a post marketing study of 9,657 patients taking ivy leaf extract
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in syrup for bronchitis whereby 95% showed improvement after 7 days of
administering the herbal preparation (Fazio et al., 2009). Other studies for
native British species include a randomised controlled study of 15 patients with
infections of the lower urinary tract that were given a cup of birch or Betula
pendula L. leaf tea to drink four times daily. After 20 days the birch leaf tea
group exhibited a 39% decrease in microbial counts of urine compared to 18%
in the control group (ESCOP, 2003).
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2.2 Materials and Methods
2.2.1 Literature Search
An initial search of the Anglo-Saxon medical literature was conducted via the
British Library online catalogue using keywords Anglo-Saxon medicine (29 hits),
Anglo-Saxon herbals (4) and Anglo-Saxon medical texts (6) to find modern
English translations of the surviving Anglo-Saxon medical literature. Further
searches using the same keywords were undertaken in academic journal
databases JSTOR, Science Direct and ISIS Web of Knowledge (Watkins et al.,
2011).
The Herbarium was chosen as the initial data source and three
translations consulted: Leechdoms, Wortcunning, and Starcraft of Early
England (Cockayne, 1864); Leechcraft: Early English Charms, Plantlore and
Healing (Pollington, 2008) and Medieval Herbal Remedies: The Herbarium and
Anglo-Saxon medicine (Van Arsdall, 2002). Two translations of Bald’s
Leechbook were examined (Cockayne, 1865; Pollington, 2008) and three works
reviewing the texts consulted (Cameron, 2006; Deegan, 1988; Meaney, 1984).
A comprehensive translation of the Lacnunga by Pettit (2001) titled Anglo-
Saxon Remedies, charms and Prayers from British Library MS Harley 585 was
used and supported by evidence from three other works (Cameron, 2006;
Cockayne, 1866; Pollington, 2008). Both Bald’s Leechbook and the Lacnunga
were reviewed for plant names in single and multiple herbal formulations used
to treat bacterial infections and wounds (Watkins et al., 2011).
2.2.2 Design of Selection Methodology
The broad concept of the selection strategy was based on Adams et al. (2009)
survey of 16th and 17th century European herbals and using principles proposed
by Cos et al. (2006) for the antimicrobial assays to determine whether the
ethnomedical formulations were appropriate for the intended use. Bacterial
infections and wounds were chosen as conditions that could be readily
identified from the medical texts; require medical treatment and are relevant to
modern health issues such as chronic leg ulcers in diabetes.
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Native British plants, not subject to any conservation orders were selected if
assigned both an Anglo-Saxon and Latin name in the Herbarium. In addition
plants had to be listed for at least two external conditions whereby bacteria
would have been present, including a puncture wound (battle injury, animal or
insect bite), burn, ear, nose or throat infection, boil or ulcer. A study of plant
names from medieval manuscripts (Hunt, 1989) was used to confirm common
and vernacular names; cross referenced in Bald’s Leechbook and the Lacnunga
for medicinal use in single and multiple herbal formulations (Cockayne, 1865;
Pettit, 2001; Pollington, 2008). The NapralertSM relational database (University
of Illinois at Chicago, USA) was accessed for published research in English on
ethno-medical studies, biological tests and known phytochemical compounds. A
phytochemistry literature search was conducted in ISIS Web of Knowledge, Pub
Med and Science Direct databases. Additional searches in antimicrobial and
phytochemical publications for potential plant candidates used keywords based
on Latin and/or common plant names and ‘antimicrobial’. The final plant
selection was based on flowering times of native British species and
underreported phytochemistry and antimicrobial activity.
2.2.3 Plant Locations
Sites were chosen within a 25 miles radius of Watford, Hertfordshire, as Oxhey,
a village in Watford, was first mentioned in an Anglo-Saxon Charter of 1007
(British Library: Cotton Nero, D.1,ff.149-61) and is near to where the author of
this thesis resides. Areas selected for harvesting plants were typical of where
an Anglo-Saxon practitioner may have collected wild specimens. Potential
locations were sourced from the ‘Flora of Hertfordshire’ (James, 2010)
combined with an online search via Google to identify landowners of harvesting
sites using keywords ‘British flora’ and ‘Herts’. Permissions were obtained
(Wildlife and Countryside Act 1981) and risk assessments authorised by
University of East London (UEL) with field trips conducted in June-August 2010/
2011 to confirm viable colonies of each species prior to collecting plant material
for analysis.
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2.2.4 Plant Collection
Botanical keys and illustrations from The Wild Flower Key (Rose, 2006) were
used to identify specimens that were collected in flower for a true identification
(Barker, 2001) and authenticated by an independent botanist, Dr. Brenda
Harold, a BSBI county surveyor. Plants were selected if they were healthy in
appearance and free of attack by insects or fungal contamination. Data
recorded for the herbarium label included geographic location, elevation, date
and time of collection (Bridson and Forman, 1999). Depending on plant size, 3-
10 specimens for each species were harvested comprising whole plants
gathered at random from colonies of at least eight plants. The harvesting
instructions in the Herbarium for B. officinalis were observed during collection of
material as in ‘this plant is very wholesome and so you must gather it in the
month of August without using a tool made of iron ... shake off the dirt... and dry
it very thoroughly in the shade’ (Van Arsdall, 2002, p.139). The plants were
collected on dry August days late morning/early afternoon using a stainless
steel trowel to loosen the roots, lifted by hand and placed in a paper bag ready
for air drying (Barker, 2001).
2.2.5 Drying and Grinding of Plant Material
Aerial parts and roots for each species were separated and air dried in a cool
dark room for five days followed by 48 h in a fan assisted oven (Gallenkamp) at
40°C to avoid degradation by microorganisms (Houghton and Raman, 1998).
The roots were brushed to remove any earth prior to drying; ground to a rough
powder using an electric blender, refined using a 500 µm sieve and stored in
the dark until required.
2.2.6 Preparation of Herbaria
Fresh specimens were arranged to reveal both sides of leaves, open flowers
and roots; loose earth brushed from the roots, plants covered with a layer of
newspaper and pressed for 2 days. The positioning of leaves, flowers and roots
were checked and weight increased for 3 weeks to dry the specimens. A
herbarium label was designed to include the Latin name, plant family,
vernacular name, collection details, habitat/ecological notes and supplementary
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data of Anglo-Saxon medicinal uses, authentication of species, collector,
voucher number and references (Appendix 1.1). Specimens and label were
mounted on white acid free paper in accordance with Kew Botanical Garden’s
guidelines (Bridson and Forman, 1999). At Kew the herbarium sheets were
placed in the deep freezer for one week to decontaminate the material and then
specimens were mounted and deposited in the Kew Herbarium for future
reference (Appendix 1.2).
 2.3Results
2.3.1 Selection Strategy
The broad keywords identified the lack of scientific evidence
Anglo-Saxon medical literature and
be read to appreciate the context in which the herbal formula
plant selection strategy shown in
plants from the Anglo
active antimicrobial compounds under scientific investigation.
decided upon in order to minimise the risk of finding no activity.
was the most appropriate
grounded in an earlier 4
2002) and comprised
outcomes could be attributed to a named plant. The
medicinal formulations for
Anglo-Saxon names
species were listed for the treatment of
puncture wound, open wound, burn, ear, nose or throat infection, boil or ulcer.
Fig. 2.1 The selection model designed to determine six plants for an antimicrobial study of
native British flora used in
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Twelve of the plants listed in the Herbarium were used in simple and
combination formulae in both Bald’s Leechbook and Lacnunga (Table 2.1)
demonstrating that species would have been reasonably accessible. Additional
criteria excluded non native species (Sambucus ebulus L. and Verbena
officinalis L.), plants not flowering in August (Glechoma hederacea L. and
Orchis mascula L.) as this month was specified in the Herbarium for harvesting
B. officinalis and Potentilla reptans. Flowering times vary according to location
and year and in 2010, Galium aparine L. had finished flowering in Hertfordshire
by the beginning of July and was therefore excluded whereas P. media was still
flowering in August. Lastly, Teucrium chamaedrys L. was excluded on the basis
of it having >100 reported compounds. The study set out to investigate plants
with underreported phytochemistry and thus Plantago media L. was chosen as
a substitute plant for P. major L. and was referenced by Cockayne (1866, p.
347) and A. minus (Hill) Bernh., as it is used interchangeably with Arctium
lappa L. in WHM.
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A phytotherapy monograph was prepared for each selected plant as shown in
Tables 2.2-2.7.
2.3.2 Plant Locations
The BSBI hectad maps (10 x 10 km) were used to determine nationwide
distribution of each species. Harvest locations and voucher numbers are given
in Fig. 2.7. and permission to collect whole specimens was obtained from: Allan
Crawley, Berry Bushes Farm, Kings Langley, Hertfordshire (Agrimonia
eupatoria L.; Arctium minus (Hill) Bernh. and Potentilla reptans L.); Paul Thrush,
Herts and Middlesex Wildlife Trust (Centaurium erythraea Rafn. from Alpine
Meadow near Berkhamstead) and Nancy Reed, Berkshire, Buckingham and
Oxford Wildlife Trust (Plantago media L. from College Lakes near Tring). Lisa
Rowley, Wildlife Trust for Bedfordshire, Cambridgeshire, Northamptonshire and
Peterborough (Betonica officinalis L. from Boddington Meadows in
Northampton) and Weston Parish Council gave permission to also collect plants
from Weston, Herts.
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Table 2.2 A Phytotherapy Monograph of Agrimonia eupatoria L.
The name of Agrimonia eupatoria is derived from Argemone, a word given by the
ancient Greeks to plants that were healing to the eyes and Eupatoria, after Mithridates
Eupatorthe, King of Pontus (120-63 B.C.) who was renowned for his herbal
formulations (Grieve, 1931).
Anglo-Saxon Name: Gar-Clive (Hunt, 1989), garclife or
‘spear-cleavers’ to describe the small burrs that stick to
clothing or animal fur (Pollington, 2008).
English Synonyms: Common Agrimony, Cockleburr
and Sticklewort.
Parts Used: Fresh and dried flowering tops.
Plant Family: Rosaceae.
Description: A. eupatoria is a hairy herbaceous
perennial with erect stems growing up to 60 cm that can
be reddish and fragrant when bruised; pinnate leaves with smaller leaflets between the
main pairs and flowers in long spikes each comprising 5 yellow petals and 5 sepals.
Flowering from June to September, the fruit is a hard
case covered in hooked spines containing two seeds
(Stace, 2010). The plant has a frequent distribution in
the British Isles except northern Scotland and is
found in hedgerows, calcareous grassy pastures and
scrubland.
Constituents: The roots and leaves mainly comprise
condensed tannins (3-11%) proanthocyanidins and
lesser amounts of hydrolysable tannins catechins,
ellagitannins and gallotannins (ESCOP, 2009).
Flavonoid glycosides of quercetin, luteolin, apigenin
and kaempferol; triterpenoids euscapic acid,
tormentic acid and ursolic acid. Others compounds
include polysaccharides, phenolic acids p-hydroxybenzoic, protocatechuic, Vanillic and
salicylic acid and steroid β-sitosterol (ESCOP, 2009; Tobyn et al., 2011; Williamson,
2003).
Source: www.british-wild-flowers.co.uk
Source: www.bsbi.org.uk
Source: www.british-wild-flowers.co.uk 
Key for last record
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Anglo-Saxon Formulations: Eight single formulations are listed in the Herbarium and
all parts of the plant used (Van Arsdall, 2002, p.164). Fresh or dried leaves were
crushed as a topical application to treat sore eyes whilst the plant was pounded in
vinegar and laid upon warts. However, 9 g of the herb in two cups of wine was
administered as an internal ‘brewit’ for snakebite and a decoction of the roots given as
a drink for soreness of the abdomen and spleen (Cockayne, 1864, p.131). In
Lacnunga, a complex formula for loin pain reads ‘fennel-seed, fresh leaves of betony,
the lower part of agrimony; grind to a powder; macerate with sweetened ale; make
tepid; give to drink hot in a standing position; let him stand for a good while’ (Pettit,
2001, p.57).
Current Herbal Use: A. eupatoria is used as a household medicinal herb and in
Western herbal practice for treating diarrhoea, irritable bowel disorders (IBD), upper
respiratory tract and urinary tract infections. An infusion is applied as a topical
antiseptic for mild skin inflammations and a gargle for throat complaints. The
recommended daily adult dose is 1-4 g of the dried herb as an infusion, 1-3 mL of fluid
extract (1:1 in 25% EtOH) or 5-10 mL of tincture (1:5 in 45% alcohol) three times per
day. (BHP, 1996; ESCOP, 2009; Tobyn et al., 2011).
Pharmacological Properties: In another related species, isolated agrimol derivatives
from Agrimonia pilosa L. have been reported to inhibit the growth of S. aureus with a
MIC range of 3.13 -50 µg/mL (Yamaki et al., 1994). In an herbal screening for
antibacterial activity against Heliobacter pylori and Campylobacter jejuni, the most
common cause of enteric infection, an EtOH extract of A. eupatoria exhibited significant
inhibition of H. pylori at 97 ± 5% and of C. jeujuni at 96 ± 30% inhibition (Cwikla et al.,
2010). Copland et al., (2003) reported an A. eupatoria seed hexane extract to have a
MIC value of 750 µg/mL against Bacillus subtilis but no activity against Gram-negative
pathogens albeit it is the herb and not the seed that is used in Western herbal practice.
Clinical Studies: In a patient study (n=20) an agrimony infusion was given 3-4 times
per day to treat cutaneous porphyrias, a blistering and fragility of sun exposed skin.
After 15 days all the patients exhibited substantial improvement in the skin conditions
(ESCOP, 2009).
Toxicity: No known side effects or toxicity have been documented however large
doses may lead to nausea and constipation (Tobyn et al., 2011).
Contraindications: Limit use during pregnancy and lactation (Barnes et al., 2002).
 Table2.3 A Phytotherapy Monograph of
The name Arctium comes from the Greek word
the furry burrs on the plant that cling to passers
lesser (Grieve, 1931).
appearance and structure to
year. In the second year strong furrowed stems grow
to 60-130 cm, spreading branches with hollow leaf
stalks and large lower leaves broadly oval to heart
shaped. Flower heads
forming burrs appearing in July to September (Barker,
2001, Rose, 2006). In the British Isles the plant is
restricted to lowland central and southern England
and borders of Wales and is occasionally found in
open woods, grassy waysides and scrubland (Barker,
2001). Medicinally the plant is
with A. lappa (Grieve,
Constituents: The leaves comprise sesquiterpenes
and sesquiterpene lactones; flavonoids luteolin,
quercetin, quercetrin and rutin (Tobyn
chlorogenic, cynarin and hydroxycinnamoylquinic acid and in the roots, polyacetylenes,
germacrolide, arctic acid and up to 50% inulin, a storage polysaccharide (Barker, 2001;
Williamson, 2003).
Source: www.british-wild-flowers.co.uk
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Arctium minus (Hill) Bernh
arktos for a bear which is reflective of
-by and minus from the Latin meaning
Anglo-Saxon Name: Personica, Boete
2002), A closely related species Arctium lappa
referred to herrif or aireve from the Anglo
meaning a thief and reafian to sieze. There is some
confusion with foxesclife and eaweyrt assigned to
multiple species (Pettit, 2001).
English Synonyms: Lesser Burdock,
Parts Used: Dried aerial parts and roots in the first year.
Plant Family: Asteraceae.
Description: Arctium minus is a biennial similar in
A. lappa although smaller and forming a rosette in the first
-
are purple with hooked bracts
used interchangeably
1931).
et al., 2011); phenolic acids caffeic and
Source: www.bsbi.org.uk
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Anglo-Saxon Formulations: Six single and two complex formulae are given in the
Herbarium (Van Arsdall, 2002, p.167) the latter two believed to have originated from
Dioscorides materia medica written in the 1st century (Riddle, 2011). All parts of the
plant were used including the fresh juice and seeds and in the case of fever, leaves
were bound to the person (Cockayne, 1864; Pollington, 2008). ‘For fresh wounds that
are still wet, take equal amounts of the roots of the same plant and hawthorn leaves;
pound them together and lay this on the wounds’. ‘For persons coughing up blood and
phlegm, four pennies weight (modern equivalent of 6.2 g) of seeds and pine nut were
made into a dumpling and given to eat’ (Van Arsdall, 2002, p.167).
Current Herbal Use: In many of the herbals A. minus is used interchangeably with A.
lappa and the latter is most often cited in the scientific literature. Arctium lappa has a
long history of being used externally to treat chronic skin conditions including eczema,
acne and psoriasis as well as internal and external use to treat impetigo, boils, cystitis,
rheumatism and gout (Tobyn et al., 2011). The recommended daily dose for an adult is
2-6 g of the infusion of the leaf or light decoction of root, 1-5 mL of tincture (1:5 in 25%
alcohol) (Barker, 2001). In addition the British Herbal Pharmacopoeia (1996)
recommends a daily adult dose of 2-8 mL for a liquid extract (1:1 in 25% alcohol), 8-12
mL for a tincture (1:10 in 45% alcohol) and a root decoction of 1:20 not to exceed 500
mL.
Pharmacological Properties: There was only one report found for A. minus in the
literature for antimicrobial activity. Sanders et al. (1945) report an aqueous juice of A.
minus aerial parts being active against B. subtilis with an inhibitory zone of 15-25 mm
compared to an inhibitory zone against E. coli of 15-20 mm. In another antimicrobial
disc diffusion assay, a 70% EtOH infusion of A. lappa flower at 400 µg/disc inhibited
growth of S. aureus (10-15 mm zone) and B. subtilis (15-20 mm ) with positive controls
of streptomycin and chloramphenicol (Moskalenko, 1986). The antimicrobial activity
against Gram-positive bacteria has been attributed to the polyacetylenes and the bitter
artctiopicrin (Barnes et al., 2002).
Clinical Studies: No published data (ESCOP, 2003).
Toxicity: No known side effects.
Contraindications: None reported.
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Table 2.4 A Phytotherapy Monograph of Betonica officinalis L.
This plant has been reassigned from Stachys officinalis to its original Linnaen name of
Betonica officinalis (Stace, 2010) named after the pre-Roman Catholics from Vettones
in Lusitania (Barker, 2001).
Anglo-Saxon Name: Biscopwyrt (Cockayne, 1864;
Hunt, 1989).
English Synonyms: Betony, Wood Betony,
Bishopswort.
Parts Used: Aerial parts should be gathered during
flowering and used fresh (Barker, 2001). Dried leaves
are used as well as the whole plant.
Plant Family: Lamiaceae.
Description: A sub genus of Stachys now classified as
Betonica with five species growing wild in Britain
(Stace, 2010). This plant is a sparsely hairy
perennial herb growing 10-60 cm; basal rosette of
long-stalked, oblong leaves in a few distant pairs
all coarsely toothed and blunt. Betonica officinalis
has red-purple flowers between June and
September (Rose, 2006). The plant thrives in
impoverished pastures in England and Wales,
except East Anglia; in open woods, hedge banks,
heaths and grasslands on acidic and calcareous
soils. However, in southern England it has declined
by 46% since the county flora records of 2005 and
is now not common anywhere in Hertfordshire
(James, 2010).
Constituents: The leaves contain alkaloids stachydrine and betonicine; diterpenes
betonicosides A-D and betaconolide; flavonoids p-coumarolyglucosides, phenolic acids
caffeic acid, verbascoside, chlorogenic acid, apigenin glycoside; up to 6% gallic acid
and 0.02% essential oil (Marin et al., 2004; Tobyn et al., 2011; Vundac et al., 2006;
Williamson, 2003).
Source: www.british-wild-flowers.co.uk 
Source: www.bsbi.org.uk
 Key for last record
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Anglo-Saxon Applications: The most frequently cited plant in the Herbarium with 29
formulations this was edited down from an initial list of 47 formulae (Voigts, 1979) for a
wide range of conditions: nightmares, shattered skull, ear, eye and throat pain,
toothache, nose bleeds, stomach pain, constipation, boils, fatigue, nausea, drinking
poison, animal bites, fever and gout. The whole plant was used although ‘for earache,
take the leaves of this same plant when it is greenest, gently boil them in water, and
press the juice out, and after it has stood for a time, warm it up again and use a piece
of wool to drip it into the ear’. A decoction of the plant in aged wine and reduced by two
thirds is given for toothache whereas the plant is ground and applied directly to the site
of an animal bite. (Van Arsdall, 2002, p.141). In Bald’s Leechbook an instruction for a
complex mixture says ‘for mist of eyes again, juice of betony beaten with it roots and
wrung, and juice of yarrow and of celandine, equally much of all, mingle together, apply
to the eye’ (Cockayne, 1865, p.31). Three European herbals during 16th century
mention B. officinalis to relieve pain in polyarthritis, gout, hip pain and lameness by
making a broth of the roots or the flowers in sugar (Adams et al., 2009).
Current Herbal Use: Betonica officinalis is used in WHM to treat tension headache,
vertigo, anxiety, hysteria, neuralgia and herbalists have prescribed it to assist in
withdrawal from benzodiazepines (Williamson, 2003). Leclerc recommends it against
sores and varicose ulcers (Barker, 2001). The British Herbal Pharmacopoeia (1996)
recommends an adult dose of 2-4 g of the dried herb or as an herbal infusion; 2-4 mL
liquid extract (1:1 in 25% alcohol) or 2-6 mL tincture (1:5 in 35% alcohol) three times
per day. Barker suggests slightly less as an infusion or 1-10 mL of tincture (1:5 in 25%
alcohol).
Pharmacological Properties: In an antibacterial study of essential oils from six
Stachys species B. officinalis inhibited growth of both B. subtilis and E. coli with a MIC
value of 100 µg/mL (Grujic-Jovanovic et al., 2004). Similar activity was seen in another
study of eight Greek species with the essential oil of Stachys scardica , inhibiting
growth of both B. subtilis and E. coli with a MIC value of 100 µg/mL compared to the
positive control Streptomycin, MIC range 10-20 µg/mL (Skaltsa et al., 2003).
Clinical Studies: No published data relating to wound healing (Tobyn et al., 2011).
Toxicity: None reported.
Contraindications: No side effects reported.
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Table 2.5 A Phytotherapy Monograph of Centaurium erythraea Rafn.
The plant name is derived from the Greek centaur Chiron, who was recognised for his
knowledge and application of medicinal plants and the word erythros meaning red
(Grieve, 1931).
Anglo-Saxon Name: Feferfuge, FelTerre, Feverwort
and Curmealle seo lœsse (Cockayne, 1864; Hunt
1989; Van Arsdall, 2002).
English Synonyms: Common Centaury, Lesser
Centaury.
Parts Used: Dried flowering aerial parts.
Plant Family: Gentianaceae.
Description: Very large genus of almost 1000 species
around the world with only C. erythraea and
Blackstonia perfoliata L. common in the British
Isles (Barker, 2001). An erect biennial growing to
50 cm with one or more stems from a basal rosette
and a few elliptical leaves. The pink rose coloured
tubular petals are longer than the narrow pointed
sepals arranged in dense forking cymes on top of
stem. This plant usually flowers between July and
August although in some years it can continue into
October (Barker, 2001; Rose, 2006). The plant is
common throughout the British Isles although
scarcer in Scotland. It is found in rough
grasslands, dunes, clearings in woods on neutral
or slightly calcareous soils and is often dwarfed in
exposed places (James, 2010; Stace, 2010).
Constituents: The bitter tasting secoiridoid glycosides in the leaves are mainly
swertiamarin. Other iridoids include centauroside, secologanin, 6’-m-hydroxy-benzoyl-
loganin, dihydrocornin, gentioflavoside and the secoiridoid alkaloid gentianine. Minor
constituents include phenolic acids p-hydroxybenzoic, Vanillic, syringic, p-coumaric,
ferulic and caffeic; phytosterols, β-sitosterol and stigmasterol and triterpenoids (Barker,
2001; ESCOP, 2003; Tobyn et al., 2011).
Source: www.bsbi.org.uk  
Source: www.british-wild-flowers.co.uk 
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Anglo-Saxon Formulations: There are six formulations in the Herbarium for
snakebite, eye pain, poor vision, ‘anyone dangerously ill’ possibly a specific medical
condition such as fever; nerve spasms, ingested poison and for the removal of worms
that ‘irritate around the anus’ (Van Arsdall, 2002, p.166). All parts of the plant are used
and often as a decoction simmered in wine and left to stand, or for snakebite the dried
plant is powdered, or the fresh plant bruised and drunk in aged wine (Cockayne, 1864).
Other Anglo-Saxon uses include fevers perhaps explaining its name of feverwort and
as a topical application to chronic wounds (Grieve, 1931; Tobyn et al., 2011).
Current Herbal Use: The main therapeutic indications are inflammatory conditions of
the upper digestive tract, dyspepsia, liver and gallbladder complaints, anorexia, and as
an appetite stimulant. Tobyn et al., (2011) recommend the root for external use of
chronic wounds with a decoction of the aerial parts in flower for acute wounds, bites
and stings. It is also used for arthritis and muscular joint pain as well as a preventative
treatment in the form of a herbal tea for irritable bowel (IBD). The recommended daily
adult dosage is 1-4 g of dried herb in 150 mL infusion or decoction of water or 2-4 mL
of a liquid extract (1:1 in 25% EtOH) three times per day (Barker, 2001; ESCOP, 2003).
Pharmacological Properties: Methanol seed extracts of C. erythraea have shown to
inhibit growth of S. aureus with a MIC value of 100 µg/mL and against S. aureus
(MRSA) a MIC value of 1000 µg/mL (Kumarasamy et al., 2002). In a subsequent study,
swertiamarin and sweroside were isolated from the aerial parts and both compounds
inhibited growth of B. subtilis and E. coli at 0.534 and 0.558 µM respectively
(Kumarasamy et al., 2003). In an air pouch granuloma assay, an aqueous extract of C.
erythraea in 2.5 and 5 % creams was shown to inhibit inflammation by 19 and 42%
respectively (Adams et al., 2009) whilst another in vivo study, a dry EtOH extract given
orally to rats at 100 mg/kg body weight inhibited carageenan-induced paw oedema by
40% (Capasso et al., 1983).
Clinical Studies: No published clinical data (Tobyn et al., 2011).
Toxicity: No known side effects.
Contraindications: C. erythraea is contraindicated for people with peptic ulcers and
should not be used during pregnancy and/or lactation (Barnes et al., 2002; ESCOP,
2003).
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Table 2.6 A Phytotherapy Monograph of Plantago media L.
The plant name is derived from the Latin word ‘planta’ meaning sole of the foot and
‘ago’ meaning like. In the United States it is commonly known as ‘white man’s foot’
believed to have grown wherever the settlers went (Grieve, 1931).
Anglo-Saxon Name: Arnoglossa and Wegbraede
(Hunt, 1989; Van Arsdall, 2002).
English Synonyms: Hoary Plantain.
Parts Used: Fresh and dried leaves and the seed.
Plant Family: Plantaginaceae.
Description: A diverse genus of 250 species three of
which have been used medicinally in Britain: P. major,
P. lanceolata and P. media with the medicinal virtues of
the latter considered being interchangeable with P.
major (Barker, 2001;
Grieve, 1931; Van Arsdall, 2002). Downy and greyish
basal rosette with blade leaf tapering to short stalk
growing from a very short rhizome with long yellowish
roots with many fine hairs and stem growing to 2-6 cm;
scented flower spike with lilac anthers pollinated by
insects. Harvest whilst in flower preferably in May to
June although can flower until August (Barker, 2001). 
In England P. media is common in chalk and
calcareous boulder clay soils of unimproved grassland,
churchyards and mown road verges (Stace, 2010).
Constituents: The leaves of P. media comprise
aucubin and plantamajoside both characteristic of the Plantago species (Ronstead et
al., 2000). Additionally P. lanceolata leaves comprise mucilage polysaccharides, iridoid
glycosides aucubin and catalpol, phenylethanoids verbascoside and plantamajoside
(Adams et al., 2009; ESCOP, 2003). Other constituents reported for P. major include
traces of alkaloids; flavonoids apigenin, baicalein, scutellarein; triterpenes, steroids,
tannins, Vitamin C, protcatechuic and fatty acids ( BHP, 1996; Williamson, 2003).
Source: www.bsbi.org.uk 
Source: www.british-wild-flowers.co.uk 
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Anglo-Saxon Formulations: Twenty one single formulations are given in the
Herbarium ranging from headaches to wounds and animal bites. All parts of the plant
used including juice ‘wrung from the plant’ for treating worms. For wounds and hot
inflammations powdered seed was applied topically whilst for snakebite the whole plant
was crushed into wine and eaten (Van Arsdall, 2002, p.144). In Bald’s Leechbook for
the same plant ‘drip into the ear juice of ribwort [P. lanceolata] and oil made lukewarm,
mingled together, it wonderfully healeth’ (Cockayne, 1865, p.41) whilst for P. major in
the Lacnunga ‘let one take greater plantain; put it in wine; drink the juice, and let one
eat the plants; then it will be good for every internal infirmity’ (Pettit, 2001, p.79).
Current Herbal Use: P. media is not used in WHM. However, the leaves and seed of
P. major are used in the treatment of blepharitis and conjunctivitis, coughs, fungal skin
infections, wounds, haemorrhoids and ulcers. By contrast P. lanceolata is used to treat
pulmonary conditions including chronic bronchitis and has a long history for healing
skin tumours (Barker, 2001) and according to Weiss (2001), is the superior species.
The recommend daily adult dose for P. major is 2-5 mL three times per day and for P.
lanceolata, a daily adult dose of 3-6 g or equivalent preparations (BHP, 1996; ESCOP,
2003).
Pharmacological Properties: There was no reported pharmacological activity for P.
media. However in another species, 50% EtOH leaf extracts of P. major inhibited
growth of S. aureus, B. subtilis, P. aeruginosa and E. coli with an inhibition zones of 10-
15mm compared to positive control, gentimicin with inhibition zone >25mm
(Samuelsen, 2000). Aucbigenin, the aglycone of aucubin has been shown to be
responsible for the antibacterial activity (ESCOP, 2003).
Clinical Studies: A syrup of P. lanceolata leaves was given to 593 patients suffering
with acute bronchitis and post-infectious dry cough, and after 10 days the symptom
score declined by >65% with physician evaluations being 25.9% excellent and 61.8%
moderate outcomes (ESCOP, 2003).
Toxicity: None reported.
Contraindications: May cause a contact allergic reaction and in excess may cause a
laxative and hypertensive effect so should therefore not be used during pregnancy
(Barnes et al., 2002) although the ESCOP monograph states no contraindications
known (2003).
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Table 2.7 A Phytotherapy Monograph of Potentilla reptans L.
Potentilla is derived from the Latin potens meaning powerful and reptans to creep or
crawl as is the habit of the plant (Tobyn et al., 2011).
Anglo-Saxon Name: Fifleafe, pentafilon, pentafolium,
filofolium (Hunt, 1989).
English Synonyms: Creeping Cinquefoil, Five
Fingers, Five-Leaf-Grass.
Parts Used: Fresh and dried leaves; dried rhizome and
the whole plant.
Plant Family: Rosaceae.
Description: There are more than 500 species
worldwide. Potentilla reptans has slender creeping
stems with five and sometimes seven leaflets. The stem roots at nodes as it creeps
and may be up to 1 m long. Small yellow flowers growing individually on long stalks
with 5 petals, 5 sepals and numerous stamen. The plant flowers from June to
September and the rhizomes are best harvested
during the autumn but may be used at any time
(Stace, 2010; Barker, 2001). It is a very common
plant of hedge banks, roadsides, open grasslands
and sand-dunes in the British Isles although not so
common in Scotland. 
Constituents: Potentilla reptans has to date only
eight reported compounds in the leaves (Tomczyk
and Latte, 2009; Napralert, 2003): ascorbic acid,
kaemperol-3-O-glucoronide, quercetin-3- O-β-D-
glucuronpyranoside, quercetin-3-7-diglucuronide,
ellagic acid, p-coumaric acid, caffeic acid and
ferulic acid. In other species triterpenoid saponins
including euscaphic acid and tormentic acid glycosides; flavonoids with 15-20% type B
proanthocyanidins and hydrolysable tannins ellagitannins including peduncluagin,
agrimoniin and laevigatin; coumarins including umbelliferone, esculetin and scopoletin;
carotenoids and sterols isolated from P. erecta (Bazylko et al., 2013; Tomczyk and
Latte., 2009; Tobyn et al., 2011).
Source: www.bsbi.org.uk  
Source: www.british-wild-flowers.co.uk 
Key for last record
*- 1970-1986 
*- 1987-1999 
*- 2000-2009 
*-2010-present 
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Anglo-Saxon Formulations: There are nine single formulations listed in the
Herbarium using the whole plant, roots or juice. For a bloody nose the instruction is
‘give him cinquefoil to drink in wine and smear the head with it; then the bleeding will
stop quickly’ (Van Arsdall, 2002, p.145). An aqueous root decoction is given as a drink
for aching joints, sore stomach, aching mouth, tongue and throat; for a burn the plant is
used topically whereas a poultice is made by simmering the whole plant in wine and
unsalted old pig grease to ‘stop an ulcerous sore from spreading’ (Van Arsdall, 2002,
p.145). In Bald’s Leechbook a simple formula reads ‘for the bite of snake again,
cinquefoil wrung and mingled with wine is good to drink’ (Cockayne, 1865, p.111).
Current Herbal Use: Potentilla reptans is not used by Western medical herbalists
although P. erecta L. is used to treat diarrhoea, relieve pain and soothe bleeding gums
and in Turkey, P. anserina L. is used to treat ulcerative colitis and as a lotion for
haemorrhoids (Tomcyzk and Latte, 2009). The recommended daily adult dose for P.
recta is 2-4 g dried rhizome as an infusion; 2-4 mL of liquid extract (1:1 in 25% alcohol)
or 2-4 mL of tincture (1:5 in 45% alcohol) three times a day and up to 10 mL as a lotion
or mouthwash for bleeding gums. (Barker, 2001, BHP, 1996; Williamson, 2003).
Pharmacological Properties: In an antimicrobial study of Potentilla species from the
Dinaric Alps the aqueous root decoction of P. reptans exhibited activity against Gram-
positive and Gram-negative bacteria including S. aureus (inhibitory zone of 10.3-12
mm), B. subtilis (7-15 mm zone) and E. coli (4.3-7.2 mm zone) compared to penicillin,
the positive control, demonstrating a 25 mm zone (Redzic et al., 2009). In a survey of
nine Potentilla species excluding P. reptans, aqueous infusions of aerial parts inhibited
S. aureus (ATC6538) within a MIC range of 12.5 - >100 mg/mL and in the same study,
P. argenta L. was the most active against Gram-negative bacteria, inhibiting E. coli
(ATCC 25922) at 50 mg/mL and P. aeruginosa (ATC 27853) at >100 mg/mL (Tomczyk
et al., 2008; Tomczyk et al., 2007).
Clinical Studies: No published data for P. reptans although in another species,
Potentilla erecta L. rhizome was shown to significantly reduce diarrhoea with no clinical
side effects in a randomised controlled study of 40 children (Subbotina et al., 2003).
Toxicity: None reported.
Contraindications: Caution is advised regarding long term use because of the high
tannin content and Tobyn et al., (2011) recommend A. eupatoria as an alternative,
being less astringent.
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2.3.3 Plant Collection
Specimens were collected in July and August for two consecutive years with all
plants harvested in 2010 and 2011, except B. officinalis that was only collected
in 2011. Each species was harvested from different colonies within the given
locations in Hertfordshire, Bedfordshire and Buckinghamshire (Fig. 2.2). The
size of each species determined the number of specimens collected ranging
from three A. minus to ten C. erythraea plants. On the day of collection P.
reptans, B. officinalis and C. erythraea were all in flower; A. eupatoria and A.
minus had flowers and fruits on the same plant whilst P. media had few flowers
and only part of the stalks intact. For A. minus only one whole plant was
harvested as one tap root was ample and for P. reptans only mature plants with
black tap roots were collected (Barker, 2001). The thin sinewy roots of C.
erythraea and high moisture content of P. media leaves meant that repeat visits
were necessary in both years to gather sufficient material for analysis. Plant
colonies for all species in 2011 were less abundant compared to the previous
year and only P. media was prolific in its environment.
Fig. 2.2 Harvesting sites for plants collected in 2010 and 2011. Voucher specimens
deposited at Royal Botanic Gardens, Kew and location references: A. eupatoria
FMW001 (TL0653000296), A. minus FMW003 (TQ0583599987), B. officinalis
FMW003 (SP4938053120), C. erythraea FMW005 (SP9887310299), P. media
FMW004 (SP9328914640) and P. reptans FMW002 (TL0611800660).
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2.4 Discussion
This research has been based on modern English translations of the Anglo-
Saxon medical literature as the author does not read the vernacular (Watkins et
al., 2012). The plant selection strategy is a robust model that could be further
utilised to investigate the 10th century texts for additional conditions relevant to
allied health and, other ancient medical texts awaiting scientific scrutiny. Battle
wounds and burns in Anglo-Saxon England were common place (Cameron
2006; Van Arsdall, 2002) and mortality rates high from sword injuries, sling shot
and arrow wounds as well as individuals being exposed to bloody lacerations on
the battlefield (Hutley and Green, 2009). Bacterial infection and wounds were
specifically chosen as descriptors for conditions readily identified in the medical
texts with minimum ambiguity. They are also relevant to global health issues
such as antibiotic resistance and increasing lifestyle disease as in chronic foot
ulcers in diabetes (Coenye and Nelis, 2010; Hancock, 2005).
The selected plants were known to the Anglo-Saxon practitioner with
each species allocated an Old English name and some more popular than
others. Betonica officinalis is the most highly cited plant in the Herbarium (29
formulations) and, the most referenced medicinal plant in the 10th century
medical literature (Deegan,1988; Voigts,1979) whereas in WHM, the plant is
used for nervous headache, nerve pain and anxiety (Williamson, 2003). With
the advent of the printing press in the 15th century and many new herbals
published, elements of traditional herbal medicine were lost over time. For
example, in the Herbarium the fresh juice of A. eupatoria was specified for
treating fresh wounds; a practice that continued to the 17th century although
now lost to traditional folklore and WHM (Allen and Hatfield, 2004; Barker, 2001;
Williamson, 2003). Centaurium erythraea is used for a different range of
therapeutic treatments in WHM compared to 10th century formulae. Tobyn et al.
(2011) recommend herbal practitioners now consider using the root to treat
chronic wounds, as described by Dioscorides, in antiquity. Some Anglo-Saxon
medicinal formulae remain as with P. major and P. lanceolata to treat upper
respiratory tract infections and external skin conditions (Adams et al., 2009).
The lesser known P. media is referenced in Bald’s Leechbook and listed in the
medicinal flora (Barker, 2001; Cockayne, 1865, p.293) as a substitute plant for
Chapter 2 – Plant Selection 
41 
 
P. major. The Anglo-Saxon practitioner would have substituted species
according to the local terrain; P. major grows well in clay, whereas in sandy
soils P. media would be most abundant (Watkins et al., 2011). Arctium minus,
P. media and P. reptans have been used interchangeably for A. lappa, P. major
and P. erecta respectively. All six species are listed in the medicinal flora
(Barker, 2001) with only the latter three being commercially available from UK
herbal manufacturers as dried herbs and tinctures.
Little is known about the phytochemistry and pharmacological actions of
the substitute plants although A. minus is often grouped with A. lappa and, in
herbal practice, is considered to be comparable even though the plants are
genetically distinct (Stace, 2010). By contrast P. reptans has been superseded
by Potentilla erecta L.; it may be that the former was more abundant in southern
England with the latter preferring acid soils of northern and Western parts of the
country (Allen and Hatfield, 2004). This correlates with an entry in Culpeper’s
Complete Herbal and English Physician (1653) that was compiled in London
and includes P. reptans but not P. erecta. The phytochemistry for A. eupatoria,
B. officinalis and C. erythraea is well reported in the literature albeit evidence of
pharmacological actions and in particular, significant antibacterial activity, was
lacking for all plants (Cwikla et al., 2010; Daglia, 2011; Skaltsa et al., 2003). In
some cases, the phytochemical literature focussed on parts of the plant that
have no traditional herbal application as in essential oil of B. officinalis and
seeds for both C. erythraea and A. eupatoria (Grujic-Jovanovic et al., 2004;
Kumarasamy et al., 2002).
Plants synthesise a significant diversity of secondary metabolites in
response to microbial infection, insect and animal predators. Many of these
constituents have been reported as effective antimicrobial agents including
alkaloids, saponins, tannins and resins (Cowan, 1999; Cushnie and Lamb,
2005; Lucas, 1998; Gibbons, 2008). Tannins, the most abundant secondary
metabolites made by plants, are widely distributed in the woody parts as well as
the leaves. Tannins have the ability to react with proteins to form water
insoluble polymers and are used in the tanning industry to transform animal
hides into leather. Plants with a large amount of tannins are generally avoided
by herbivores owing to the astringent taste and less protein being accessible to
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the digestive juices (Barbehenn and Constabel, 2011; Daglia, 2011; Harborne
and Williams, 2000). The antibacterial properties of tannins are well known and
prominent amounts reported in the leaves of B. officinalis (6% gallic acid), A.
eupatoria (>7% catechin and epicatechins), Rosa damascena L. (8% gallic acid
equivalents) and for P. reptans 15-20% proanthocyanidin and hydrolysable
tannins in the leaves and roots (ESCOP. 2009; Ozturk et al., 2009; Tobyn et al.,
2011). Polyacetylenes have been reported for A. lappa and Plantago species
with a wide range of biological functions including antimicrobial, antifungal and
anti-inflammatory activity (Adams et al., 2009; Cowan, 1999). Verbascoside, a
caffeic glycoside ester present in the leaves and roots of Betonica, Plantago
and Potentilla species, is reported to have in vitro antimicrobial activity against
Gram-positive and Gram-negative bacteria and in vivo activity inhibiting
arachidonic acid induced mouse ear oedema (Adams et al., 2009; Fons et
al.,1998; Tomczyk and Latte, 2009).
The Anglo-Saxon authors were aware that the medicinal properties of
plants vary during the growth cycle and, where considered important, instructed
how and when to collect the plants (Cameron, 2006; Cockayne, 1864; Van
Arsdall, 2002). In an antimicrobial study of Hypericum perforatum the aerial
parts collected in August inhibited growth of S. aureus (15 mm zone) and E. coli
and P. aeruginosa (6 mm zone) compared to inactive specimens harvested in
July (Borchardt et al., 2008). A phytochemical study by Southwell and Bourke
(2001) confirmed that hypericin, the active principle of hypericum, increased
fourfold when flowering of the plant had nearly finished, compared to
648-981 pmm in the preceding two weeks. In another study, aucubin an iridoid
glycoside with anti-inflammatory activity was found to have a higher
concentration in the leaves of P. major (1.3%) when harvested in June
(Samulsen, 2000).
For millennia many native British plants have been used medicinally and
some continue to be prescribed by practitioners of WHM whilst others are no
longer used as a result of exotic imports, changing uses of landscapes, over
harvesting or plant toxicity (Watkins et al., 2011). Wild plants were used in this
study to:
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• mimic the activity of an Anglo-Saxon practitioner collecting local
material
• be reasonably sure that the plants had not been fertilised or
genetically enhanced from cultivated sources
• perform analysis using minimal amounts of plant material
compared to classical phytochemical methods that typically use 1-
2 kg of plant material for an initial phytochemistry screening
(Houghton and Rahman, 1998).
There was a noticeable difference in the abundance of species at the
locations visited in 2010 and 2011 showing that plants continually adapt and
respond to the environmental conditions. Betonica officinalis, favours
impoverished hay meadows and has with evolving agricultural methods,
declined significantly in southern England during the last 25 years (James,
2010). By contrast, P. major an example of the Plantago species, is common
globally and cultivated as a medicinal horticultural crop in Brazil (Zubair et al.,
2011).
The author previously reported three native British species A. millefolium,
H. perfortaum and M. vulgare all listed in Anglo-Saxon formulations, are well
researched with in vitro and in vivo studies, revealing bioactive metabolites that
underlie the uses in the medieval medical texts (Watkins et al., 2011). Whilst the
antimicrobial literature is limited for the plants in this study, many of the
secondary metabolites reported would be beneficial in treating bacterial
infections and wounds; flavonoids, kaempferol and quercetin glycosides exhibit
antibacterial, anti-inflammatory and potent radical scavenging activity as well as
inhibition of fibroblast growth (Daglia, 2011; Harborne and Williams, 2000).
Procyanidin-enriched fractions from Plantago ovata Forskal have also shown to
stimulate the proliferation of keratinocytes in the wound healing process
(Houghton et al., 2005). In this study, aqueous, EtOH and wine formulations
for six native species will be screened for in vitro antimicrobial activity to
determine whether they would have been appropriate in the 10th century wound
healing formulations.
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Chapter 3.0 Antimicrobial Bioassays
3.1 Introduction
In ethnopharmacological studies, complex plant mixtures and isolated pure
compounds are initially screened in vitro (Houghton et al, 2005). Wound healing
assays have been developed for antimicrobial, anti-inflammatory, antioxidant,
fibroblast proliferation and collagen lattice formation. These methods can be
performed in a relatively short period in the laboratory. In terms of screening
plants with little or no known phytochemistry, in vitro assays are more cost
efficient and ethical than in vivo studies at the preliminary stage of investigation
(Adams et al., 2009; Annan and Houghton, 2008; Cos et al., 2006).
Wound healing progresses through three distinct stages: haemostasis or
the staunching of blood flow; inflammation including pain and swelling soon
after injury and regeneration or remodelling, taking up to 2-3 weeks for
complete healing to occur (Majno and Joris, 1996; Suntar et al., 2010). Wound
infection is a clinical diagnosis that includes pain, redness, splitting of tissue,
discharge and sinus or abscess formation (Hutley and Green, 2009). By
contrast, a clinical infection is defined as an internal or external site whereby the
pathogens reach a concentration in excess of 105 /mL and overcome the host’s
immune system (Black and Costerton, 2010; Siddiqui and Bernstein, 2010).
The discovery of penicillin by Alexander Fleming in 1928 (Rishton, 2008)
led to a better understanding of infectious disease and more effective treatment
for wounds. The main classes of antibiotics used in the West and the
mechanistic actions against Gram-positive and Gram-negative pathogens are
shown in Table 3.1. A variety of broad-spectrum antibiotics, derived from
microbes, were widely used until the 1990s, resulting in increased bacterial
resistance and, more recently, multi-drug resistance (Gibbons, 2008;
Theuretzbacher, 2009). A drug causing bacteriostatic action involves
intracellular disruption of the RNA and/or DNA preventing cell reproduction
whilst not necessarily killing the microbial cell (Kohanski et al, 2010).
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By contrast, bactericidal action is defined as death of the microbial cell via
degradation of the cell wall. The drug or pure compound also needs to be
selective in its action by only attacking the microbial cell and having minimal
effect on host cells at the therapeutic dose, for example, macrolides and
aminoglycosides (Hancock, 2005). Gram-positive S. aureus is largely
associated with skin infections and drug action against this organism is
predominantly bactericidal by inhibiting cell wall synthesis as in β-lactam
pencillin (Dewick, 2009; Hancock, 2005). Gram-negative pathogens are more
complex in structure having an outer cell wall thereby decreasing permeability
of the drug and efflux pumps on the cell membrane, capable of rendering the
drug inactive (Gibbons, 2008; Kuete et al., 2008). Deep wounds are
polymicrobial, prone to chronic infection, and potentially provide an entry point
for bacteria to enter the host and produce a systemic infection (Houghton et al.,
2005).
Many indigenous cultures use plants topically and systemically to treat
bacterial infection and wounds for example Echinacea purpurea L. In WHM this
species is used externally to treat superficial wounds and internally as an
adjuvant for recurrent respiratory and urinary tract infections (ESCOP, 2003;
Gibbons, 2008; Savoia, 2012). Heinrich et al. (2012) describe lemon balm
Melissa officinalis and garlic Allium sativa as broad spectrum antibiotics
inhibiting both Gram-positive and Gram-negative bacteria. In the Anglo-Saxon
medical texts A. minus is used in a similar manner: the juice of the leaves
mixed with wine as a herbal wound drink; the plant boiled and the liquid used as
an antiseptic wash with the residue pounded in grease and applied as a poultice
(Van Arsdall, 2002, p.167).
Ethnomedical knowledge can be a useful tool in identifying plants that
may yield new leads in drug development (Adams et al., 2009; Gibbons, 2008)
and the Anglo-Saxon medical texts may yet prove to be a valuable source of
indigenous plant knowledge for further investigation. The aim of this chapter is
to experimentally determine in vitro whether the selected plants (A. eupatoria,
A. minus, B. officinalis, C. erythraea, P. media and P. reptans) would have been
appropriate for the Anglo-Saxon treatment of bacterial infection and wounds.
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3.2 Materials and Methods
3.2.1 Chemicals
Chloramphenicol (Sigma Aldrich), dimethyl sulphoxide (DMSO), formic acid (50
%), HPLC grade EtOH and MeOH were obtained from Fisher Scientific UK Ltd
and red wine (Cabernet Sauvignon, 2007; Barkan Classic, barcode:
7290000023809). Nutrient broth (CM0001) and nutrient agar (CM0003) were
purchased from Oxoid Limited; distilled water purified using a reverse osmosis
system (Purelab Option S).
3.2.2 Extraction of Plant Material
The basic concept of the methodology followed antimicrobial protocols
proposed by Cos et al. (2006) and Rios and Recio (2005) both widely cited in
the literature. The plants were divided into two experimental groups determined
by availability of material and an experimental code assigned to each extract
(Appendix 2.1). Aerial parts and roots for each species were separated and air
dried in a cool dark room for five days followed by 48 h in a fan assisted oven
(Gallenkamp) at 40°C to avoid degradation by microorganisms. The material
was ground to a rough powder using an electric blender, refined using a 500 µm
sieve and stored in the dark in sealed glass jars for further use (Houghton and
Rahman, 1998).
Grounded aerial parts and roots (2 g) were separately macerated for 24
h in 20 mL cold solvent (25% and 75% EtOH in H2O, red wine) making four
EtOH and two wine extractions for each plant. For the hot extracts additional
H2O was used to accommodate the expansion in plant material; the infusion
was prepared with 40 mL boiling H2O to 2 g of dried aerial parts and left to
infuse for 10 min with container covered to prevent vapour loss. For the
decoction, 100 mL H2O was added to 2 g of roots, boiled then simmered for 20
min and reduced to a third (Van Arsdall, 2002). The supernatant for each crude
extract was filtered (Whatman No. 11), evaporated to 5 mL using reduced
pressure under vacuum (Buchi Syncore) at 45°C, transferred to a drying block
(Techne Dri-block) at 40°C for 1-2 days. Stock solutions (20 mg/mL) comprised
60 mg of crude extract dissolved in 3mL DMSO (100%) using an ultrasonic
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water bath (QHKerry) for 30 min and stored at 4°C for further use (Cos et al.,
2006).
3.2.3 Microbial strains
The four microorganisms selected for the in vitro bioassays were representative
of those commonly used in the antimicrobial screening of natural products
(Kumarasamy et al., 2003; Moskalenko, 1986; Quave et al., 2008). The four
bacterial strains were Gram-positive Staphylococcus aureus (NCTC 7447),
Bacillus subtilis (NCTC 3610), Gram-negative Escherichia coli (UEL 57) and
Pseudomonas aeruginosa (NCIB 8295). The E. coli isolate was independently
serotyped by the Gastrointestinal Infections Unit, Health Protection Agency,
Colindale as E. coli as rough serotype, H49 (Appendix 3.1). A rough strain is
determined by the loss of the O-Antigen and shorter core oligosaccharides
whilst retaining the lipid portion in the outer membrane of gram-negative
bacteria (Triantafilou et al., 2000).
3.2.4 Bacterial Cultures
Four to five colonies were transferred from nutrient agar plates to 5 mL sterile
nutrient broth and incubated at 37 °C overnight. The bacterial concentration for
each pathogen was standardised using a spectrometer (Jenway 6305) with
optical density readings of 0.1 at 600 nm
.
The spectrometer was calibrated with
1 mL of sterile nutrient broth and following absorbance reading, cultures diluted
with sterile nutrient broth to an inoculum density of 1.5 x 106 colony forming units
(CFUs) (Kuete et al., 2009). The standardised inoculum was seeded in sterile
nutrient broth 15 min before filling the 96-well microtitre plate (Cos et al., 2006).
A loop of overnight culture was streaked on to an agar plate (Oxoid) and
incubated at 37°C for 18 h for all microorganisms to verify no contamination in
the bacterial cultures.
Viable colonies were maintained of each species by preparing new agar
plates every 2-3 weeks and stored at 4 °C until required. Reserve supplies of
bacterial cultures comprised 4.5 mL of inoculum added to 1.5 mL glycerol in
saline solution (40%) and were stored at minus 20°C and minus 80°C for future
use. Growth curves were conducted for each typed culture in a round bottomed
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96-well microtitre plate; 195 µL nutrient broth and 5 µL of standardised inoculum
for each microorganism was placed in quadruplicate cells, incubated at 37 °C
with optical density readings of 600 nm recorded at 0 min and subsequently
every 60 min for 18 h. Bacterial growth was calculated plotting hourly
absorbance readings over time and experiment repeated on three independent
days (n=3). An antibiotic susceptibility test (MASTRING-STM) was performed
using 8 impregnated tips to confirm the selected Gram-positive and Gram-
negative bacteria (M13 and M27 respectively) were not resistant to reference
antibiotic, chloramphenicol. Nutrient agar plates were streaked with overnight
culture, antibiotic tips applied to the media and plates incubated at 37 °C
overnight and zone of inhibition measured.
3.2.5 Antimicrobial Assay
The microdilution method was used for the in vitro antimicrobial screen,
prepared in round bottomed 96-well microtitre plates and conducted according
to NCCLS (2009) protocol. Wells were filled with 100 µL plant extract at final
concentrations of 200, 40 and 8 µg/mL, 95 µL nutrient broth and 5 µL inoculums
at the standardised concentration of 1.5 x 106 CFUs (an optical density reading
of 0.1 at 600 nm). Sterile nutrient broth was seeded (5 % inoculums) and placed
on a vibrating plate for 15 min before use (Cos et al., 2006; Rios and Reico,
2005). Chloramphenicol was used as the reference antibiotic and positive
control (Houghton et al., 2005), nutrient broth with DMSO (1% final
concentration) as the negative control, nutrient broth seeded with inoculums for
bacterial growth control, and nutrient broth only wells to ensure no
contamination was present.
One 96-well microtitre plate was used for each plant per organism and
the layout is shown in Fig. 3.1. The wine extracts were prepared on a separate
microtitre plate with a red wine control, making a total of twenty plates per
experiment. Each plant extract and control was performed in quadruplicate and
repeated on three independent days (n=3). Each plate was assigned a unique
code that was carried through to file name when exporting pre and post
incubation absorbance data into Microsoft Excel software. Bacterial growth was
determined by taking optical density readings at 600 nm at 0 h (t1) and again at
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18 h (t2) after incubating at 37°C without agitation. The plate reader was
programmed to shake each microtitre plate for 10 seconds prior to each
reading. The percentage of bacterial growth inhibition (PBGI) was calculated as
follows:
PBGI= 100 - ( (t2-t1) / Mean growth of control cells x 100).
 
A B C D E F G H
 
200 µg/mL 40 µg/mL 8 µg/mL 200 µg/mL 40 µg/mL 8 µg/mL
1 1 1 1 2 2 2 7 9
2 1 1 1 2 2 2 7 9
3 1 1 1 2 2 2 7 9
4 1 1 1 2 2 2 7 9
5 3 3 3 4 4 4 7 9
6 3 3 3 4 4 4 7 9
7 3 3 3 4 4 4 7 9
8 3 3 3 4 4 4 7 9
9 5 5 5 6 6 6 8 10
10 5 5 5 6 6 6 8 10
11 5 5 5 6 6 6 8 10
12 5 5 5 6 6 6 8 10
Fig. 3.1 96-well microtitre plate layout for each plant comprising 6 aqueous/EtOH
extracts at screening concentrations of 200, 40 and 8 µg/mL. A separate plate was
prepared for wine extracts. Key Infusion (1), Decoction (2), Leaf 25% EtOH (3), Root
25% EtOH (4), Leaf 75% EtOH (5), Root 75% EtOH (6), Nutrient Broth (7),
Chloramphenicol (8), DMSO at 1% (9) and blank cells (10). Plate layout adapted from
Cos et al., (2006).
3.2.6 Statistical Analysis of Data
A control group was created for each organism comprising12 wells (4 from each
experiment) to confirm any significant difference between the intra and interday
experimental data. The Shapiro-Wilk test was used to assess the normality of
the data (Field, 2005; Razali and Wah, 2011). One way Analysis of Variance
(ANOVA) was used to establish any statistically significant differences between
plant extracts and also the control groups for each organism (p <0.05) using
Microsoft Excel 2007 software. The MIC50 and MIC90 values were determined
as 50% and 90% of the inhibtion of bacterial growth expressed as ± standard
error of the mean (SEM) of three independent bioassays (n=3).
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3.3 Results
3.3.1 Extraction of Plant Material
A total of 50 aqueous, EtOH and red wine extracts were prepared from the six
selected plants including a red wine control. Ground material (2 g) was used to
prepare each extract with the largest leaf yield being A. minus infusion (530
mg) compared to A. eupatoria 25% EtOH extract (104 mg). For the roots, P.
reptans decoction produced the largest yield (1232 mg) and C. erythraea 75%
EtOH extract the smallest yield (42 mg) (Appendix 3.2).
3.3.2 Antimicrobial Assay
The antimicrobial assay was an initial screen of the six selected plants at 200,
40 and 8 µg/mL. The full MIC and MBC activity for the most potent extracts will
be discussed in Chapter 5. The Shapiro-Wilk test (Table 3.2) confirmed that
there was no significant difference in the normality of the activity after removing
plant extracts identified as outliers (B. officinalis 75% EtOH leaf against S.
aureus, root wine against B. subtilis and both 75% EtOH roots of B. officinalis
and P. media against P. aeruginosa).
Table 3.2 P values (p <0.05) for Shapiro Wilk's test to determine normality in 
the distribution of plant extracts inhibiting growth of Gram-positive and 
Gram-negative wound pathogens. 
Plant S. aureus B. subtilis P. aeruginosa E. coli 
A. eupatoria 0.371 0.473 0.242 0.274 
A. minus 0.116 0.544 0.712 0.745 
P. reptans 0.792 0.351 0.453 0.184 
B. officinalis 0.307 0.852 0.769 0.081 
C. erythraea 0.855 0.804 0.064 0.411 
P. media 0.689 0.865 0.499 0.535 
A summary of IC50 values from the initial antimicrobial screening of all six plants
against Gram-positive and Gram-negative bacterial commonly found in wounds
is shown in Table 3.3.
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Table 3.3 Summary of IC50 values for the antimicrobial screening of
selected plants at 200, 40 and 8 µg/mL against Gram-positive and Gram-
negative wound pathogens – there were no IC50 values for any extracts
against P. aeruginosa.
Plant extracts S. aureus B. subtilis E. coli
Agrimonia eupatoria
Leaf Infusion 200 - 200
Leaf Wine 40 - -
Leaf 25% EtOH 40 - -
Leaf 75% EtOH 40 - -
Root Decoction 8 40 40
Root 25% EtOH 40 200 200
Root 75% EtOH 40 200 -
Arctium minus
Leaf 25% EtOH 200 200 -
Root Decoction 200 - -
Root Wine - 200 -
Root 25% EtOH 40 200 -
Root 75% EtOH 200 200 -
Betonica officinalis
Leaf Wine - 200 -
Leaf 25% EtOH - 40 -
Leaf 75% EtOH - 200 -
Root Decoction 200 200 -
Root 25% EtOH - 8 -
Centaurium erythraea
Leaf Infusion - 200 -
Leaf Wine - 200 -
Leaf 25% EtOH - 40 -
Plantago media
Leaf Infusion - 8 -
Leaf 25% EtOH - 40 -
Root Decoction - 8 -
Root 75% EtOH - 8 -
Potentilla reptans
Leaf Infusion 200 - -
Leaf 25% EtOH 200 40 -
Root Decoction 200 40 40
Root Wine - 200 -
Root 25% EtOH 40 200 200
Root 75% EtOH 8 - -
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All plants demonstrated greater activity against the Gram-positives than Gram-
negative pathogens. The leaf and root wine extracts exhibited the weakest
activity with 4 plants having MIC50 values of 200 µg/mL against B. subtilis (B.
officinalis, C. erythraea, A. minus and P. reptans). Only A. eupatoria leaf wine
extract inhibited growth of S. aureus at the lower concentration of 40 µg/mL.
None of the wine extracts exhibited MIC values against the Gram-negative
bacteria.
The aqueous and EtOH leaf extracts demonstrated greater antimicrobial
activity inhibiting Gram-positive bacteria in three or more samples with C.
erythraea and P. media infusions the most potent against B. subtilis (MIC50 8
µg/mL) and against S. aureus, A. eupatoria 25% and 75% EtOH leaf extracts
(MIC50 40 µg/mL) as shown in Appendices 3.3 and 3.4. Against Gram-negative
pathogens A. eupatoria infusion was the only leaf extract to inhibit E. coli (MIC50
200 µg/mL (Appendix 3.5). None of the leaf extracts inhibited growth of P.
aeruginosa (Appendix 3.6).
The roots were more active than the leaves against Gram-positive
bacteria with all aqueous and EtOH extracts (except C. erythraea) exhibiting
MIC50 values in two or more extracts at 40 µg/mL (Fig. 3.2). One B. officinalis
and two P. media EtOH root extracts demonstrated MIC50 values of 8 µg/mL
against B. subtilis (Appendix 3.7). The most potent root extracts to inhibit growth
of S. aureus were A. eupatoria decoction and P. reptans 75% EtOH root (MIC50
8 µg/mL) with both plants exhibiting activity in a dose dependent manner (Fig.
3.2). The root decoctions for the same two plants were the only mixtures to
demonstrate MIC50 value of 40 µg/mL against E. coli (Fig. 3.3). The P. reptans
root decoction also exhibited 48% inhibition of E. coli at 8 µg/mL whereas the
only root extract to inhibit >40% growth of P. aeruginosa was A. eupatoria 25%
EtOH root (Appendix 3.8).
The A. eupatoria 75% EtOH root extract demonstrated the greatest
range of inhibitory growth against S. aureus with a MIC90 at 200 µg/mL to a
MIC50 at 40 µg/mL. The most potent preparations inhibiting S. aureus were A.
eupatoria decoction and P. reptans 75% EtOH root extracts (MIC50 8 µg/mL) in
a dose dependent manner. The only plants to inhibit growth of Gram-negative
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E. coli were A. eupatoria and P. reptans (MIC50 40 µg/mL). A one way analysis
of variance (ANOVA) showed there was no statistical difference between the
activity of the two plants (p = 0.5324).
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Fig. 3.2 S. aureus antimicrobial screening results for root extracts (from left to right) at
200, 40 and 8 µg/mL. Key: Dec Roots in boiling H2O; RW Red wine; R25 25% EtOH;
R75 75% EtOH and CHL Chloramphenicol (positive control). ** denotes significant
inhibition (p<0.01).
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Fig. 3.3 E. coli antimicrobial screening results for root extracts (from left to right) at 200,
40 and 8 µg/mL. Key: Dec Roots in boiling H2O; RW Red wine; R25 25% EtOH; R75
75% EtOH and CHL Chloramphenicol (positive control). * denotes significant inhibition
(p <0.05).
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3.4 Discussion
Many indigenous cultures use plants to treat bacterial infection topically and
systemically (Gibbons, 2008) although for the plants in this study, there was
limited or no evidence of significant in vitro antimicrobial activity against wound
pathogens. Relevant pharmacological studies were found for some plants
including anti-inflammatory and analgesic activity (Adams et al., 2009; Capasso
et al., 1983; ESCOP, 2003).
The phytochemical literature reported on parts of the plant that have no
traditional use in WHM as in C. erythraea and A. eupatoria seeds and the
essential oil of B. officinalis (Copland et al, 2003; Kumarasamy et al., 2002;
Skaltsa et al., 2003). The following of classic phytochemical methods would
have entailed decrepitating compounds from the plant extracts that may have
antimicrobial activity, for example, chlorophylls and tannins, prior to the in vitro
screening (Houghton and Rahman,1998; Harborne, 1998) . However, in this
instance the hypothesis set out to establish whether the plants used in 10th
century Anglo-Saxon formulations may have been appropriate in treating
wounds and therefore no constituents were removed prior to screening activity.
There is evidence of water soluble chlorophyll extracts being used successfully
to treat chronic wounds not responding to orthodox treatment (Mowbray, 1957).
It is estimated that 400-500 mg of pure compound is required to conduct
comprehensive in vitro and in vivo studies which equates to 100 kg of dried
plant material (Machesney et al., 2007). This is not a viable option when
collecting specimens from the wild for species that may or may not be active.
The microdilution assay is a quantitative method used to determine in vitro
activity for liquid extracts (Cos et al., 2006) and combined with chemo metrics is
a more economical method for identifying compounds that significantly
contribute to the antimicrobial activity (Roost et al., 2004). The model designed
for this study used <30 g of dried material for both the in vitro bioassay and
chemical analysis of each species. The hot extracts were more dilute
extractions (1:15 for the roots and 1:20 for the leaves) yet exhibited greater
antimicrobial activity than the cold extracts (1:10 for roots and leaves).
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The UEL 57 teaching strain of E. coli was independently confirmed as a rough
strain meaning that the lip polysaccharides (LPS) have lost part or all of the O-
polysaccharides resulting in the outer membrane having greater permeability
that could reduce the effectiveness of the organism resistance to many
antibiotics. In this study, the E. coli strain was only susceptible to the most
potent extracts of A. eupatoria and P. reptans demonstrating that loss of the O-
chain in this species did not make the organism susceptible to all plant extracts
or to the antibiotic control, Chloramphenicol in the Mastering test.
The aqueous infusions, decoctions and red wine extracts were chosen to
reflect the liquid solvents used in Anglo-Saxon wound healing formulations (Van
Arsdall, 2002). The lyophilise compounds extracted by the animal fat
formulations could have been tested using hexane but were not part of this
project. The 25% EtOH were representative of solvents commonly used in
WHM (Bone, 2003; Mills and Bone, 2007) and the 75% EtOH extracts as
examples of solvents used in classic phytochemical analysis (Harborne, 1998).
Anglo-Saxon formulae specify various vehicles for both topical and internal
‘brewits’ (Table 1.2) including honey, vinegar, wine, dairy products and animal
grease (Cameron 2006; Pettit, 2001; Van Arsdall, 2002). Phytochemical
analysis would be conducted on specific samples with the underlying premise
that the active metabolites would be present, albeit in very small quantities. The
full bodied cabernet sauvignon was chosen as an example of an ‘old wine’
specified in the texts for both systemic and topical preparations (Van Arsdall,
2002) and at 13% vol, may explain why the wine extracts were less active than
the 25% EtOH mixtures.
There is evidence of wine being imported from Europe during the Anglo-
Saxon era as well as being produced locally with more than 38 vineyards
recorded in the Doomsday Book in 1086 (Voigts, 1979). Ale and prepared fruit
wines including blackberry, elderberry, raspberry and mulberry were common
drinks. Dioscorides in the 1st century recommended British mead being superior
to other European sources (Hagen, 2006; Riddle, 2011). The strength of wine
during 10th century is not known although it must have contained >10% alcohol
in order not to become acetic acid during transit and according to Hagen (2006)
a fruit wine could have reached 18-20% vol. The health benefits of red wine
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today are attributed to the many polyphenols including gallic acid and ellagic
acid known to inactivate bacteria by cell wall synthesis (Annan and Houghton,
2008; Daglia, 2011; Garcia-Ruiz et al., 2011). Supercritical extracts from Merlot
pomace demonstrated activity against S. aureus (MIC 625 ±375 to 750 ±250
µg/mL) and to a lesser extent, activity against Gram-negative pathogens E. coli
and P. aeruginosa with MIC values of 1000 µg/mL (Oliveira et al., 2013). All
plants in this study exhibited MIC50 values in either leaf or root wine extracts at
200 ug/mL against B. subtilis (except P. media) and only A. eupatoria leaf wine
extract exhibited activity against S. aureus at 40 ug/mL.
In an in vitro bioassay of Plantago major, a species in the same genus as
Plantago media, aqueous extracts of the aerial parts inhibited 78% of B. subtilis
at 400 ug/mL whereas a hexane extract inhibited the same organism at 50
ug/mL (Velasco-Lezama et al., 2006). By contrast, the leaf infusion of P. media
in this study was more active against B. subtilis (MIC50 8 ug/mL). The A.
eupatoria 25% EtOH was the most potent leaf extract inhibiting growth of S.
aureus (MIC50 40 ug/mL) compared to a hexane extract of A. eupatoria seeds
reported to have a MIC value of 750 ug/mL (Copland et al., 2003). Leaf extracts
for A. minus, C. erythraea and P. media against Gram-positive bacteria
exhibited growth in the wells that was greater than the control cells. Sanders et
al. (1945) commented on a similar observation in A. minus samples which they
attributed to the plant extract providing growth factors or similar compounds.
Another theory is that the bacterial cell “became enlarged” as a result of one or
more plant compounds crossing the cell membrane; one of the known
mechanisms of emodin is the “ability to elongate” the bacterial cell (Izhaki,
2002). It is not possible to determine the antimicrobial mechanisms of the plant
extracts in this study as the active metabolites are unknown.
Plant roots have greater applications in Traditional Chinese and African
medicines with the use of leaves more prominent in WHM; perhaps reflective of
availability in the local environment? An EtOH root extract of white horehound
Marrubium vulgare was shown to be a potent inhibitor of MRSA with IC50 values
of 32 µg/mL (Quave et al., 2008). Only one antimicrobial study was found in the
literature for roots of the selected plants; an agar disc diffusion assay for P.
reptans aqueous decoction that inhibited S. aureus (10-12 mm zone of
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inhibition) and E. coli (4-7 mm zone) (Redzic et al., 2009). In this study, the
most potent root extracts were the decoctions and 75% EtOH mixtures of A.
eupatoria and P. reptans with activity against Gram-positive (MIC50 8 µg/mL)
and Gram-negative pathogens (MIC50 40 µg/mL) although the roots of A.
eupatoria are not used in WHM (ESCOP, 2009; Tobyn et al., 2011).
Antimicrobial activity for crude plant extracts is considered to be
significant at concentrations below 100 µg/mL (Cos e al., 2006; Rios and Recio,
2005) although in the literature many plant extracts are reported as being active
at much higher concentrations for example, a MeOH extract of Hypericum
perforatum was considered active against S. aureus with a MIC of 1250 µg/mL
(Saddiqe et al., 2010). Many authors have cited a MIC based system by
Aligiannis et al. (2001) with levels of up to five times greater than those of Cos
et al. (2006), thereby creating confusion in the literature as to what is
considered a strong, moderate or weak inhibitor (Roersch, 2012). Whilst none
of the extracts in this study exhibited full MIC values at the screening
concentrations, all of the plants (except A. minus) exhibited MIC50 values of 8
µg/mL in one or more extracts against Gram-positive bacteria, suggesting they
are worthy of further investigation. However, plants active against Gram-
positive and Gram-negative pathogens are more likely to combat infection and
assist in permanent wound healing (Hutley and Green, 2009). Both A. eupatoria
and P. reptans root extracts were active against S. aureus (MIC50 8 µg/mL) and
against E. coli (MIC50 40 µg/mL) and whilst they were the most potent overall in
the antimicrobial screening, a one way ANOVA showed there was no significant
difference between the two plants. Therefore all plants were analysed using
HPLC and multivariate analysis before deciding which extracts would be
investigated for the active antimicrobial metabolites.
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Chapter 4.0 Plant Metabolite Mapping
4.1 Introduction
Biosynthetic pathways are fundamental to metabolism and plants within the
same taxonomic family often have related therapeutic actions. Thousands of
secondary metabolites are produced from a small quantity of primary
metabolites, of which a large number are defence mechanisms used to deter
microbial and fungal invaders as well as insects and herbivores (Dewick, 2009;
Harborne and Williamson, 2000). For example, cocoa Theobroma cacao L. has
been shown to produce a broad range of antimicrobial compounds including
sulphur when under attack from a vascular wilt virus (Dixon, 2001). Surprisingly,
this diversity arises from a distinctly small number of chemical classes mainly
terpenoid, phenylpropanoid, flavonoid and alkaloid/polyketides outlined in Fig.
4.1 (Marienhagen and Bott, 2013).
The terpenoids are of pharmacological importance even though they are
only present in relatively small quantities. These compounds are synthesised
via the mevalonate pathway. Phenylpropanoids are derived from the shikimate
pathway with hydroxycinnamic acids having many therapeutic actions. For
example, the analgesic and anti-inflammatory properties of caffeic acid result
from inhibition of DOPA-decarboxylase and 5-lipoxygenase enzymes. Caffeine
and berberine, the most widely distributed nitrogen containing alkaloids, occur
in the leaves, roots, fruits and seeds of flowering plants (Dewick, 2009; Ganora,
2009; Pengally, 2004). Flavonoids are produced via the shikimate and acetate
pathways with varying degrees of solubility ranging from highly polar tannins to
non polar quercetin and kaempferol. These compounds are plant pigments that
protect tissue against UV radiation and are anti-inflammatory, antioxidant as
well as enzyme inhibitors (Harborne, 1998).
The use of hyphenated analytical instruments including high performance
liquid chromatography (HPLC) and high resolution mass spectrometry (HR-MS)
form the basis for non targeted analysis to identify peaks in plant extracts of
unknown phytochemistry (Kite et al., 2007). This is fundamental where
availability of plant material is insufficient for traditional phytochemical methods
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Fig. 4.1 Biosynthetic pathways for main chemical classes of primary and secondary
plant metabolites (with permission and adapted from Marienhagen and Bott, 2013).
such as isolation and fractionation of the active constituents (Houghton and
Raman, 1998). The presence of thousands of metabolites in a plant extract
makes the spectral data too complex to analyse visually and, whilst some peaks
may be matched to available reference standards, the activity could be from an
unknown compound and require further analysis (Kueger, 2012).
Chemometrics as defined in the 1970’s, is a branch of chemistry that
applies a combination of mathematical models to interrogate and extract
meaningful data from complex experimental data for example, HPLC, LC-MS
and NMR (Roos et al., 2004; Wold, 1995). More recently, the term
metabolomics has been used to describe qualitative and quantitative studies of
all metabolites present in a given biological system including plants (Heinrich et
al., 2012). Metabolomics has a wide range of applications including the quality
control of phytomedicines; defining chemical variations in plants grown at
different locations and, in botany, used to confirm taxonomic markers for
different species (Kueger eta al., 2012; Yuliana et al; 2011). Roos et al., (2004)
Terpenoids 
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have shown there is a specific correlation between the spectral pattern of St.
John’s Wort Hypericum perforatum extracts and the corresponding IC50 activity
in both in vitro and in vivo studies. The mapping of pharmacological activity onto
chemical features using multivariate data analysis (MDA) to determine the
active principles in a phytochemical formulation can also be applied to analysing
unknowns in complex plant mixtures (Bailey, 2004; Gao et al., 2010; Holmes et
al., 2006). Herbal fingerprinting as applied to analytical data such as HPLC and
NMR can be interpreted with principal component analysis (PCA), an
unsupervised pattern recognition method.
PCA uses linear transformation to reduce large and complex datasets to
a minimal number of new dimensions that show the dominant patterns in a data
matrix (Tistaert et al., 2011; Wold, 1995). The peak retention time on the X axis
and UV absorbance units on the Y axis data is transformed to a new set of
variables called principal components (PCs) that are orthogonal to each other ,
with PC1 explaining the greatest variance in the dataset and successive PCs for
the remaining variances (Eriksson et al.,1999; Holmes et al., 2006). Score plots
are used to visually determine similarities of samples by clustering and
differences, by sample separation whether chemical class and/or solubility of
the plant extracts. The score plots overlaid with bioactivity, may indicate which
principal components are relevant to the activity of the herbal extracts (Gao et
al., 2010; Roos et al., 2004; Wold, 1995). The loading plots derive the weighting
or value of the contributing variables (HPLC tR), with the data points furthest
from the origin in the quadrant of interest considered significant to the bioactivity
(Gao et al., 2010; Holmes et al., 2006; Liu et al., 2012; Wold, 1995).
The aim of this chapter is to obtain a HPLC chemical fingerprint for all 50
plant extracts and, using PCA modelling, elucidate which sample might be
selected for further investigation and identify the active antimicrobial
compounds.
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4.2 Materials and Methods
4.2.1 Materials
DMSO, HPLC grade MeOH, ascorbic acid, caffeic acid, ellagic acid, esculin,
trans-ferulic acid (99%), gallic acid, kaempferol, naringenin , p-coumaric acid ,
phenol, quercetin, quinic acid, rutin, rosmarinic acid and vanillic acid were
purchased from Sigma Aldrich; formic acid (50%) from Fluka; scopoletin from
Acros and β-sitosterol from Calbiochem. Distilled water was obtained using a
reverse osmosis system (Purelab Option S).
4.2.2 HPLC Method
The reversed phase HPLC assay utilised an internal Medicines Research
Group (MRG) method for uncharacterised herbal extracts. The HPLC system
(Agilent 1200 series) comprised a Quaternary pump (G1311A), degasser
(G13221), autosampler (G1329A), column oven (G1316A) and diode-array
detector (G1316A). Ultraviolet (UV) data were acquired from 200-360 nm with
210, 254 and 320 nm wavelengths selected for monitoring. A Zorbax Eclipse
C18 analytical column (150 x 4.6 mm i.d.; 5 µm) was maintained in the column
oven at 25°C using a flow rate of 1 mL/min. The starting mobile phase
comprised aqueous 0.01% formic acid in distilled water (A) and MeOH (B) with
initial conditions set at 25% B with a linear gradient to 90% B at 30 min and
retained for 2 min. The solvent was returned to 25% B at 34 min and the column
equilibrated for 6 min giving a total gradient cycle of 40 min.
Two hundred microlitres of stock solution of plant extract (20 mg/mL in
DMSO) was centrifuged for 5 min (13,000 rpm) and 100 µL transferred to HPLC
vial and diluted tenfold in 900 µL starting mobile phase (Sanchez-Medina et al.,
2007). Solvent controls were prepared for DMSO (10%), MeOH and red wine.
Internal reference standards (2 mg) were dissolved in 1 mL MeOH, placed in a
sonicating water bath for 20 min and centrifuged for 5 min (13,000 rpm). The
sample injection was 20 µL (n=3) resulting in 40 µg total on the column and
samples were stored at 4°C for further use.
The HPLC chromatogram data was acquired using Agilent 1200
Chemstation software (Rev B.04) resulting in 6000 discrete regions. Data points
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were acquired between 0.00 and 40.00 min at 210, 254 and 320 nm. The HPLC
chromatogram data for all six plants including peak height and retention time
(tR) were exported into Microsoft ® Excel 2003 as comma separated value
(.CSV) files and subsequently combined into one master Excel file per species
at each of the selected wavelengths. Quality of the HPLC data was confirmed
using the coefficient of variation (CV) at 210 nm for tR and area of main peak in
each plant extract.
4.2.3 Principal Components Analysis (PCA)
The methodology used in this study was developed by Gao et al. (2010) who
used PCA to confirm active metabolites in a traditional herbal preparation of
Scutellaria baicalensis L. prescribed in China as an adjuvant for the treatment of
lung cancer. Multivariate data analysis was performed using SIMCA-P+, version
12.00 software (Umetrics, Sweden). The Excel HPLC files were imported into
SIMCA-P+, data transposed with Variable and Primary Id tags assigned.
Unsupervised models for each species were constructed for principal
components to determine the main variance in each data set; score plots for
similarities and differences between the plant extracts and loading plots to
determine retention times (tR) for the potentially active compounds. Following
analysis of raw and normalised datasets, the former was used to avoid
impacting clarity of the HPLC peak tR in the loading plots (Gao et al., 2010). The
full acquisition data set (0-40 min) was analysed prior to removing background
noise when the column was equilibrated during the last 6 min. This resulted in
4500 data points retained for further analysis with a total of 72 samples for each
plant (8 extracts x 3 replicates at each of the three selected wavelengths).
A principal components model was created for each species with PC1
attributable for the main variance in the data set and score plots generated for
each species. Hotelling’s model (95% confidence) was applied to all data sets
to determine outliers (Field, 2005). Score plots generated for each plant were
superimposed with antimicrobial activity at each of the screening concentrations
of 200, 40 and 8 µg/mL against the Gram-positive and Gram-negative bacteria.
The loading plots show the correlation between variables and were used to
determine which peak or peaks tR significantly contributed to the antimicrobial
activity (Roos et al., 2004).
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4.3 Results
4.3.1 HPLC Method
The HPLC diode array chromatograms for the root extracts (Fig. 4.2) are shown
at 254 nm with polar peaks eluting in the first 10 min and non polar peaks
towards the end of the gradient run. This wavelength was used to visually
compare HPLC peaks for plant metabolites as the solvent peak was not
present. Greater intensity for metabolites was at 210 nm with polar compounds
co-eluting in the first 5 min followed by a series of less polar peaks at 10-20 min
with a series of smaller non polar peaks in the subsequent 15 min. At 320 nm
the y-axis response was poor for all plants.
A number of reference compounds gave the same peak tR for some plant
extracts indicating a potential match for these metabolites (Table 4.1). These
included caffeic acid at 6.25 min (A. minus, B. officinalis and C. erythraea),
ferulic acid at 10.32 min (A. minus), rutin at 11.98 min (C. erythraea) and
kaempferol at 19.21 min (A. eupatoria). These known antimicrobial compounds
are ubiquitous in plants and are reported in the monographs in Chapter 2,
Tables 2.2-2.7. The most dilute samples were the leaf and root red wine
extracts with many peaks observed at 320 nm albeit in small quantities.
The leaf extracts exhibited a series of highly polar HPLC peaks in the
first 5 min and a subsequent range of lesser polar peaks between 8-13 min
(Appendix 4.1). The 25% EtOH leaf extracts were generally more active than
the 75% EtOH leaf samples and at 254 nm there were major peaks at 5.00 min
(B. officinalis) and 8.88 min (B. officinalis and Plantago media) that did not
match any of the reference compounds although had a similar retention time to
the p-coumaric acid standard. There was a greater concentration of peaks in
the root extracts with more non polar peaks between 15 and 25 min (Fig.. 4.2).
The root extracts were the most active against both Gram-positive and Gram-
negative organisms (A. eupatoria and P. reptans). Overall, the hot root
decoctions contained a greater intensity of HPLC peaks than the leaf infusions.
This was reflective of the extraction method with the leaves (1:20) steeped for
15 min compared to the roots (1:15) being boiled and simmered for 20 min.
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Whilst all plants exhibited MIC50 values in one or more extracts, the three most
active plants were A. minus, A. eupatoria and P. reptans (Fig. 4.3). The HPLC-
UV 254 nm chromatogram for A. minus shows the main peak at 10.5 min. This
may correlate to the ferulic acid standard and was present in both leaves and
roots. The A. eupatoria extracts showed a series of highly polar peaks in the
first 5 min followed by a second series at 10-15 min and a third series in the
subsequent 10 min. The early eluting polar peaks in the first 2 min that may be
quinic acid or gallic acid whilst the main peak at 19.5 min correlated to the tR of
kaempferol standard. By contrast, the P. reptans leaf and root extracts showed
a major peak in the first 2 min followed by a series of smaller peaks eluting
during the first 15 min, a smaller range in the subsequent 10 min with β-
sitosterol (tR 30.03 min) confirmed by matching tR of reference standard. The y
axis showed the peaks in the P. reptans extracts were noticeably more dilute
compared to A. minus and A. eupatoria extracts (Fig. 4.3).
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Retention time (tR)
Fig. 4.3 HPLC-UV 254 nm chromatograms of leaf and root extracts for A. minus (top),
A. eupatoria (middle) and P. reptans (bottom). Key: leaf infusion (blue), 25% EtOH leaf
(red), 75% EtOH leaf (pink), root decoction (green), 25% EtOH root (gold) and 75%
EtOH root (purple).
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4.3.2 HPLC-PCA Metabolite Mapping
The HPLC-PCA 210 nm scores plot for principal component 1 (PC1) versus
principal component 2 (PC2) represents the distribution of samples in
multivariate space, and is used to discern differences and similarities between
plant extracts and each species. The 210 nm model expresses a good fit for all
plants with PC1 and PC2 accounting for > 80% of variance in each data set
(except B. officinalis) and, for P. media and P. reptans models >90% of the total
variance. Each set of coloured triangles in Fig. 4.4 represent an individual plant
extract for P. reptans and its replicates (n=3).
When the antimicrobial activity against S. aureus was mapped on to the
score plot, the most potent extracts (75% EtOH root and root decoction)
appeared in the top left hand quadrant. PC1 for A. eupatoria accounts for 70%
of the variance versus PC2 of 11% (data not shown) and for P.reptans, 78% of
the variance is due to PC1 and 12% to PC2 (Fig. 4.4), demonstrating there is no
significant difference between the two plants. The contribution or loading plot
has been shown to discriminate peak retention times that significantly contribute
to the antimicrobial activity (Roos et al., 2004). The loading plot for A. eupatoria
indicated activity may be related to a peak with tR between 19.05 and 20.34
min, and this correlated to the HPLC tR for the kaempferol reference standard
(data not shown). The contribution line plot for P. reptans in Fig. 4.5 illustrates
the two peaks identified in loading plot that were farthest from the origin and
therefore considered significant contributors to the activity of the 75% EtOH
extract. This activity was associated with HPLC peaks around 2.29 and 21.86
min.The initial retention time may be gallic acid or a derivative at 2.16 min whilst
none of the reference standards matched the later retention time. Only two
plants, A. eupatoria and P. reptans, demonstrated MIC50 values against Gram-
positive S. aureus (MIC50 8 µg/mL) and Gram-negative E. coli (MIC50 40
µg/mL). Score plots for A. eupatoria and P. reptans overlaid with activity against
E. coli show the most active extracts positioned in the bottom left and right hand
segments indicating there may be more than one active compound present.
C
h
a
p
te
r 
4
 –
 M
e
ta
b
o
li
te
 M
a
p
p
in
g


7
2
 
 
 
Fi
g.

4.
4
Un
su
pe
rv
ise
d
HP
LC
-
PC
A
21
0
n
m

sc
o
re

pl
ot

fo
r
P.

re
pt
a
n
s
le
af

a
n
d
ro
o
te
xt
ra
ct
s
o
ve
rla
id

w
ith

a
n
tim
icr
o
bi
a
la
ct
ivi
ty

a
ga
in
st

S.

a
u
re
u
s
at

th
re
e
sc
re
e
n
in
g
co
n
ce
n
tra
tio
n
s
of

20
0
(A
,
B,
C,

D,

E
a
n
d
H)

40

(F
)a
n
d
8
µg
/m
L
(G
).A

co
lo
u
re
d
tri
a
n
gl
e

re
pr
e
se
n
ts

o
n
e

re
pl
ica
te

fo
r
e
a
ch

pl
a
n
te
xt
ra
ct

(n=
3).

Ke
y:

A
Le
a
fI
n
fu
sio
n
;B

Le
af

25
%

Et
O
H;

C
Le
af

75
%

Et
O
H;

D
Le
af

W
in
e
;E

Ro
o
tD
e
co
ct
io
n
;F

Ro
o
t2
5%

Et
O
H;

G

Ro
ot

75
%

Et
O
H
a
n
d
H
Ro
ot

W
in
e
e
xt
ra
ct
.




-
50
 0


50
 
-
15
0 
-
10
0 
-
50
 
0
50
 
10
0 
15
0 
A
 
  
  
  
B
 
C
 
D
 
H
 
  
  
  
  
 E
 
F
 
  
  
  
 G
 
M
IC
5
0
 ≥
2
0
0
 µ
g
/m
L 
M
IC
5
0
 8
 µ
g
/m
L 
M
IC
5
0
 4
0
 µ
g
/m
L 
PC
2
(12
%
)
PC
1
(78
%
)
C
h
a
p
te
r 
4
 –
 M
e
ta
b
o
li
te
 M
a
p
p
in
g


7
3
 
    
Correlation(scaleof+1to-1)
-
0.
03
0 
-
0.
02
0 
-
0.
01
0 
0.
00
0 
0.
01
0 
0.
02
0 
0.
03
0 
0.
04
0  
0
 
 
 
 
 
10
 
 
 
 
 
 
20
 
 
 
 
 
 
30
 
 
 
 
 
 
Fi
g.

4.
5
H
PL
C-
PC
A
21
0
nm

co
n
tri
bu
tio
n

lin
e

pl
ot

fo
r
P.

re
pt
a
n
s
sh
o
w
e
d
pe
a
k
t R

a
t2
.
29

m
in

(1)

a
n
d
21
.
86

m
in

(2)

fro
m

th
e

lo
a
di
n
g
pl
o
tt
ha
tm
a
y
si
gn
ifi
ca
n
tly

co
n
tri
bu
te

to

th
e

a
n
tim
ic
ro
bi
a
la
ct
ivi
ty

(R
o
o
s
e
ta
l.,

20
04
).
P
C
2
 
P
C
1
 
(1
) 
(2
) 
HP
LC

Re
te
n
tio
n

tim
e

(m
in
)
Chapter 5 – Phytochemistry of P. reptans 

74 
 
4.4 Discussion
Compounds without chromophores such as mono and disaccharides as well as
co-eluting metabolites, would not be detected in the HPLC chromatograms and
therefore not detected in the PCA analyses, even though they may have been
present in the extracts tested for antimicrobial activity (Harborne, 1998; Kite et
al., 2013). The PCA modelling of plant extracts and antimicrobial activity
allowed us to determine which samples were selected for further investigation,
and how best to optimise the LC-MS method for profiling the active metabolites.
The metabolite profile of the most potent extracts will be further explored in
Chapter 5 using liquid chromatography mass spectrometry (LC-MS) and high
resolution mass spectrometry (HR-MS).
There was no prior separation of plant samples by traditional methods for
example, hexane to extract the lipophillic compounds, as one of the key aims
was to determine whether the aqueous and EtOH extractions used in 10th
century Anglo-Saxon formulations would have been appropriate for the intended
use. Multiple compounds may elute with the same retention time under any
conditions so whilst some peaks matched the internal standards, further HPLC
analysis is required to spiking the extracts with pure reference compounds to
show an increase in peak intensity under the same conditions. The hot plant
extracts prepared in this study (1:15 for the root decoctions and 1:20 for leaf
infusions) required more solvent than the cold extracts. The dry plant material
needed more solvent as it expanded from the heat and, as a result, the extracts
were dilute solutions compared to a commercial herbal EtOH tincture (1:3) used
in WHM; suggesting greater activity would have been achieved with more
concentrated extracts.
The PCA analyses were performed using the original HPLC data, without
normalisation, in order to preserve locating the peaks significantly contributing
to the antimicrobial activity (Gao et al., 2010; Roos et al., 2004). HPLC-UV 210 nm
peaks were more concentrated in the hot infusions and decoctions compared to
the cold EtOH extracts as seen in Fig. 4.2. Gao et al., (2010) developed a PCA
model to confirm activity of known phytomarkers in Scutellaria baicalensis L.
root used in China as an adjuvant to orthodox chemotherapy for lung cancer. By
contrast, this study utilised PCA to correlate unknown plant chemistry as
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detected by the HPLC-UV 210 nm chromatograms with bioactivity from the
antimicrobial screening for all six plants. The HPLC-PCA 210 nm score plots when
overlaid with activity against S. aureus showed the most active extracts for the
majority of plants to be in the top left and lower right quadrants indicating that
the active compounds would be from a selective range of chemical compounds.
The two exceptions were the C. erythraea root decoction positioned in the
bottom right quadrant and A. minus EtOH leaf and root extracts in the top and
bottom right hand quadrants respectively indicating a different class of
compounds being responsible for the activity (data not shown).
In Chapter 3 it was found there was no significant difference between the
antimicrobial activity of A. eupatoria and P. reptans against gram-positive S.
aureus and gram-negative pathogen E. coli. Here in Chapter 4, the
HPLC-UV 210 nm chromatograms show on the y axis that the peaks in the P.
reptans extracts are more dilute than the corresponding A. eupatoria samples,
suggesting the isolated compounds of P. reptans would be more potent
(Fig.4.3). The contribution line plot indicated specific HPLC peaks found furthest
from the origin in the loading plot that may be attributable to this antimicrobial
activity (Fig.4.5). Ultimately, P. reptans was chosen for further investigation
based it being more active than A. eupatoria against E. coli and it only having 8
reported compounds for the leaves (Tomczyk and Latte, 2009).
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Chapter 5.0 Phytochemistry of Potentilla reptans
5.1 Introduction
Potentilla reptans was a common component in Anglo-Saxon wound healing
formulations (Cockayne, 1865; Van Arsdall, 2002). In Bald’s Leechbook the
plant was considered to be interchangeable with Potentilla aserina L. although
the leaves of both plants are visually very different (Stace, 2010). Use of P.
reptans continued in herbal practice until 17th century (Culpeper, 1653) and
thereafter was replaced with Potentilla tormentilla L., the preferred plant used in
current Western herbal practice (Barker, 2001; Tobyn et al., 2011). In Turkey,
P. reptans is used medicinally to treat heartburn and abdominal pain. In an in
vivo study the leaves were found to be effective in treating ethanol induced
peptic ulcers (Gurbuz et al., 2005; Tomczyk and Latte, 2009) whereas the
Chippewa in North America steep the root of Potentilla arguta L. to stop
bleeding after bloodletting, for headache, cuts, diarrhoea, inflammation and as a
tonic (McCutcheon et al., 1995).
A phytochemical and pharmacological review of the Potentilla species
(Tomczyk and Latte, 2009), identified a total of 67 compounds previously
reported for the roots and rhizomes of 11 species. Forty three compounds have
been structurally elucidated for Potentilla erecta L., compared to 143
compounds identified for the aerial parts of more than 20 species, of which 57
were flavonoids including many O-glycosides (28) and O-glucuronides (6). The
main chemical classes in the Potentilla species are phenolic compounds
comprising condensed and hydrolysable tannins, triterpenoids and coumarins in
both leaves and roots with flavonoids primarily isolated from the aerial parts of
the plant (Table 5.1). Many species have been reported having antimicrobial
activity and there is a long tradition for within the genus for it being used to treat
diarrhoea and dysentery (Tobyn et al., 2011; Tomczyk and Latte, 2009). There
is little known about the phytochemistry of P. reptans with only eight compounds
isolated from the aerial parts for example: isoquercitrin, miquelianin,
kaempferol, ellagic acid, caffeic acid, p-coumaric acid, ferulic acid and
isosalipurposide (Tomczyk and Latte, 2009). The pharmacological activity
reported for these compounds is relevant to wound healing with IC50 values in
antioxidant, radical scavenging and antihemoragic assays (Fig. 5.1).
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Table 5.1 Main phytochemistry reported for roots in Potentilla species (adapted
from Tomczyk and Latte, 2009).
Compounds Potentilla species References
Flavonoids
Kaempferol Potentilla argentea L., Potentilla
recta L., Potentilla discolor L.
(Tomczyk, 2006;
Tomczyk, 2011; Song et
al., 2013)
Hydrolysable
Tannins
Agrimoniin P. recta, Bazylko et al. (2013)
Ellagic acid P. anserina, P. argentea,
P. discolor, P. recta, Potentilla
multifida L., Potentilla chinensis L.
(Tomczyk,2006;
Tomczyk, 2011;
Xue et al., 2006)
Condensed
Tannins
Catechin P. erecta, P. anserina, P. alba Tomczyk and Latte,
(2009)
Epicatechin Potentilla alba L, P. erecta (Oszmianski et al., 2007)
Procyanidins P. alba, P. erecta (Oszmianski et al., 2007;
Tomczyk and Latte, 2009)
Triterpenoids
Ursolic acid P. anserine Li et al. (2003)
Tormentic acid P. erecta Csuk et al. (2012)
Euscaphic acid P. anserine Li et al. (2003)
Tormentoside P. anserina, P. erecta (Csuk et al., 2012;
Jang et al., 2007)
Organic acids
Gallic acid P. discolor (Song et al., 2013; Xue et
al., 2006)
p-coumaric acid P. alba Oszmianski et al., (2007)
Others
β-sitosterol P. argentea, P. anserina (Li et al., 2003; Tomczyk,
2006)
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isoquercitrin
11.7 [µM] in DPPH assay
(Jeong et al., 2011) a 
quercetin 3-O-glucuronide
6.3 [µM] in thiobarbituric acid assay
(Marzouk et al., 2006) b 
kaempferol
0.84 [µM] in nitric oxide assay
(Cos et al., 1998) c
 
ellagic acid
10.5 [µM] against Candida albicans
(Li et al., 2001) d 
caffeic acid
2.78 [µM] against S. aureus
(Srivastaba et al., 2007) e 
p-coumaric acid
0.19 [µM] against Protobothrops flavoviridis
(Aung et al., 2011) f 
ferulic acid 0.2 [µM]
against Protobothrops flavoviridis
(Aung et al., 2011) g 
isosalipurposide
3.9 [µM] in DCFH-DA assay
(Agnihotri et al., 2008) h 
Fig. 5.1 IC50 values for compounds isolated from P. reptans leaves. Chemical structures
reported by Saddiqe et al., (2010) a, Boly et al., (2011) b, De Melo et al., (2009) c, Tomczyk,
(2011) d, Dewick, (2009) e ,f ,g and Agnihotri et al., (2008) h.  
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5.2 Materials and Methods
5.2.1 Antimicrobial Assay (MIC and MBC)
Following the initial antimicrobial screen, a full MIC assay was conducted for P.
reptans at 10 serial concentrations using the microbroth dilution method (2-
0.004 mg/mL). Materials and methods were based on methodology in 3.2.3
(Rios and Reico, 2005; Cos et al., 2006; NCCLS, 2009). Dried crude (48 mg)
was reconstituted in 1 mL (240 µL DMSO and 760 µL nutrient broth) and
sonicated for 30 min prior to diluting in 11 mL sterile nutrient broth (4 mg/mL
with DMSO at 2%). The antimicrobial activity was calculated using the formula
give in 3.2.5 with MIC50 and MIC90 being 50% and 90% inhibition of bacterial
growth and >99% inhibition determined as a full MIC value. Minimum
bactericidal concentration (MBC) was confirmed by inserting a sterile loop into
the well of lowest concentration with no visible growth, streaked onto a sterile
nutrient agar plate, incubated at 37°C for 18 h and checked for any bacterial
growth.
5.2.2 Optimised HPLC Method
The original HPLC method described in 4.2.2 was optimised to achieve
resolution of the early eluting polar peaks. The optimised HPLC method was
based on approach by Sánchez-Medina et al. (2007). Crude extract (2 mg) was
dissolved in H2O/methanol (25/75% v/v) and centrifuged for 5 min (13,000 rpm).
The supernatant was transferred to a HPLC vial and diluted with the starting
mobile phase to give a final concentration of 1 mg/mL. The starting mobile
phase comprised aqueous 0.01% formic acid in distilled water (A) and methanol
(B) with initial conditions set at 2% B with a linear gradient to 60% B at 30 min,
90% B at 31 min and retained for 4 min. The gradient was returned to 2% B at
36 min and the column equilibrated in the start conditions for 7 min giving a total
gradient cycle of 43 min. The sample injection was 20 µL (n=3). Coefficient of
variation for peak tR and area were determined to ascertain reproducibility of
HPLC data.
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5.2.3 Optimised HPLC-PCA
Data from the optimised HPLC method was analysed using PCA methods
detailed in 4.2.3 (Gao et al, 2010; Roos et al., 2004) to determine tR of the
compounds significantly contributing to the antimicrobial activity in the loading
plot. The HPLC chromatogram data for each file was divided into 6450 discrete
regions by acquiring three data points every second between 0.00 and 43.00
min, with the last seven minutes eliminated to remove background noise during
column equilibration, resulting in 5400 data points retained for further analysis.
5.2.4 Liquid Chromatography Mass Spectrometry (LC-MS)
The optimised HPLC approach was used to develop an in house method for
LC-MS analysis in order to identify molecular mass for metabolites of interest. A
reference standard was prepared using quinic acid (1 mg) dissolved in 1 mL of
acetonitrile with 100 µL diluted tenfold, centrifuged at 13,000 rpm for 5 min and
200 µL supernatant transferred to LC-MS vial. Plant extract (1 mg) was
dissolved in 250 µL H2O and 750 µL acetonitrile, sonicated for 20 min and
centrifuged at 13,000 rpm for 5 min. Supernatant (200 µL) was transferred to a
vial and stored at 4 °C ready for analysis.
The Shimazdu LC-MS system comprised pump (LC-20AB), degasser
(DGU-20A), autosampler (SIL-20A), UV-VIS detector (SPD-20A) and mass
spectrometer (LCMS-210EV) controlled by LMSolutions software (version 3.2)
and used to analyse the data. The UV detector was set to acquire data in a
range of 200-360 nm with 210 nm selected for monitoring. Chromatographic
separation was performed on an Eclipse XDB-C18 analytical column (150 x
2.1µm id, 5 µm particle size) with the oven temperature set at 27°C. The
starting mobile phase comprised aqueous 0.01% formic acid (A), and
acetonitrile (B) with initial conditions set at 5% B with a linear gradient to 30% at
40 min; 90% at 45 min (3 min) and gradient returned to 30% at 50 min and
column equilibrated to initial conditions at 55 min. The total gradient cycle was
60 min with a flow rate of 0.25 mL/min. The P. reptans root decoction and 75%
EtOH root extracts were injected (5 µL) in triplicate.
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The mass spectrometer was set to acquire spectral data from m/z 100 to 1000
in both negative and positive ion mode with alternating sampling frequency at 2
Hz. The heater block temperature was set at 250 °C and CDL at 200 °C;
nebulising gas flow (1.5 L/min), detector voltage (1.50 kV) and the IG vacuum at
1.3e-003 Pa.
5.2.5 High Resolution Electrospray Ionisation Mass Spectrometry
(HR-ESI-MS)  
Sample preparation is detailed in 5.2.4. Accurate mass measurements and MSn
analyses were performed by Geoffrey Kite at the Jodrell Laboratory, Royal
Botanic Gardens Kew, using a Thermo Scientific 'LTQ-Orbitrap XL' linear ion
trap-orbitrap hybrid mass spectrometer with sample introduction via a Thermo
Scientific 'Accela' LC system. The instruments were controlled by XCalibur
software (version 2.0.7). Chromatographic separation was performed on a
Phenomenex Luna C18 (2) column (150 mm × 3 mm i.d., 3 µm) using a 1
mL/min mobile phase gradient of 90:0:10 to 0:90:10 (water/methanol/acetonitrile
+ 1% formic acid) over 20 min, followed by 5 min column wash in end
conditions. The column was equilibrated in the start conditions for 3 min prior to
sample injection of 5 µL. The column eluate was monitored by a photodiode
array detector over the range of 200-600 nm before introduction into the mass
spectrometer.
The interface with the mass spectrometer was via a Thermo Scientific
'Ion-Max' electrospray source, tuned according to the manufacturer's standard
recommendations and operated in polarity switching mode. The orbitrap
analyser of the hybrid mass spectrometer monitored the ion beam in positive
mode at high resolution (30,000), while the ion trap surveyed the ion beam in
the range m/z 125-2000 in both positive and negative modes at low resolution.
The ion trap survey scans in both polarities were each followed by data
dependent MS2 and MS3 scans. The most abundant non-excluded ion in the
MS1 survey scan was selected for MS2 analysis and excluded from re-analysis
for 6 seconds, while the two most abundant ions in each MS2 spectrum was
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subjected to MS3 analysis. For all MSn spectra the ion isolation window was +/-
2 m/z units and the normalised collision energy 35%. Both the orbitrap and ion
trap were mass calibrated according to the manufacturer's standard procedure
(Kite et al., 2013).
 
5.2.6 Identification of unknowns
The HPLC-PCA 210 nm loading plots indicated tR of compounds having a
significant contribution to the antimicrobial activity. Initial LC-MS analysis
provided putative molecular weights and a compound database was compiled
from the literature. Accurate mass and mass spectra were obtained for
compounds of interest and compared to in-house spectral reference library
(Jodrell Laboratory). Matches were searched for in one or more databases
including the Dictionary of Natural Products (http://dnp.chemnetbase.com),
NIST Chemistry WebBook, (http://webbook.nist.gov) and Pub Chem database
(http://pubchem.ncbi.nlm.nih.gov). A phytochemical literature search was
conducted for putative compounds regarding m/z values, reported structures
and MIC values for antimicrobial activity against gram-positive and gram-
negative pathogens commonly found in wounds.
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5.3 Results and Discussion
5.3.1 Antimicrobial Assay
The MICs for P. reptans root extracts and controls against gram-positive and
gram-negative bacteria are given in Table 5.2. The 75% EtOH root extract was
the only sample to exhibit a MIC50 to full MIC range (31.25 to 1000 µg/mL)
against S. aureus and a MIC50 (500 to 1000 µg/mL ) against E. coli and P.
aeruginosa respectively. Against E. coli, the root decoction (MIC50 3.9 µg/mL)
was as effective as the reference antibiotic chloramphenicol at the lowest
concentration.
Table 5.2 The MIC50 values (µg/mL) of P. reptans root extracts for growth inhibition 
against Gram-positive and Gram-negative pathogens commonly found in wounds. 
P. reptans extracts S. aureus B. subtilis P. aeruginosa E. coli 
Decoction 62.5 125 - 3.9 
75% EtOH* 31..25-1000 500 1000 500 
Root wine 250 - - 1000 
Red wine control 250 - -  
Chloramphenicol* 3.90-31.25 3.90-125 7.81-500 3.90-62.50 
* Range of inhibition from MIC50 to total MIC (>99% inhibition) 
In this study the root extracts of P. reptans exhibited greater antimicrobial
activity than the leaves and have demonstrated greater MIC values against S.
aureus, P. aeruginosa and E. coli than those reported for other Potentilla
species (Tomczyk et al., 2008).
5.3.2 Optimised HPLC Method
The HPLC-UV 210 nm chromatogram for the optimised method (Fig. 5.2)
demonstrates the separation of early eluting polar peaks (tR 1-5 min) evidenced
in the initial HPLC screening and with increased resolution, this gradient
approach was used to develop an in house LC-MS method.
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5.3.3 HPLC-PCA Mapping of Optimised Data
The HPLC-PCA 210 nm score plots using the optimised data showed separation
of the P. reptans extracts in a new position (Appendix 4.2). The main variance
in the optimised score plots is due to the 1st principal component (PC1, 67%)
with PC2 accounting for a further 13%.
The replications of each extract are more disparate and the 75% EtOH
root extracts distinctly separate from the other samples. Supervision of the
antimicrobial activity against S. aureus overlaid onto the score plot showed
three distinct clusters: those at 200 µg/mL were poor to intermediate inhibitors;
the 25% EtOH root samples at 40 µg/mL were more active and the 75% EtOH
root extracts at 8 µg/mL exhibited the highest activity (Watkins et al., 2012). The
loading plot for the optimised data depicts the relationship between the different
samples and the loading line plot (Fig 5.3) was used to determine which of the
HPLC peaks in the 75% EtOH root, were significantly different compared to all
Potentilla extracts (24 replicates).
The red squares in Fig. 5.3 indicate the optimised HPLC peak in the P.
reptans 75% EtOH extract with a tR of ~33.38 min having a significant
contribution to the antimicrobial activity and corresponds to the HPLC-UV peak
D in Fig. 5.2. It is noticeable in this particular extract, PC1 is attributable to a
high level of procyanidins (tR 8-30 min) and therefore with only a minimum
amount of material available, LC-MS was selected as the method for separation
and identification of the active compounds.
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5.3.4 LC-MS and HR-ESI-MS Analysis
The Potentilla reptans decoction and 75% EtOH root extracts were analysed
using the Shimazdu instrument in order to compile a list of potential candidates
in positive and negative ion mode, molecular weight and chemical formula. HR-
MS chromatograms and accurate mass data for both extracts were provided by
Dr Geoffrey Kite, Jodrell Laboratory at Kew. Similar chromatogram profiles were
obtained on the Shimadzu and Accela systems with the latter used to confirm
accurate mass for the compounds of interest (Fig. 5.4).
The HR-ESI-MS chromatograms for both root extracts in negative
ionisation mode (Appendix 5.1) showed a series prominent molecular peaks at
m/z 387.1 (tR 1.7 min), m/z 577.1 (tR 5.22 min), m/z 289.2 (tR 5.84 min) and m/z
695.3 (tR 15.7 min). The mass spectra for both extracts in positive ionisation
mode showed prominent molecular peaks at m/z 579.1 (tR 5.2 min), m/z
291.1(tR 5.8 min) and m/z 489.4 (tR 16.1 min) shown in Fig. 5.4. All of the major
peaks observed in both positive and negative ion mode are shown in Table 5.3
with those of interest labelled A-G. A number of HPLC peaks not investigated
further include compounds that matched reference standards and have been
reported for antimicrobial activity (Table 4.1); for example, β-sitosterol (tR 24.8
min) is ubiquitous in plants and present in Potentilla freyniana (Wu et al, 2009).
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5.3.4.1 Compounds A, B and C
The HR-MS chromatograms for P. reptans root decoction and 75% ETOH
extracts in the positive ionisation mode (Table 5.3) showed two major [M+H]+
peaks at m/z 579.1 (A) and m/z 291.1 (B). These protonated molecules may
correspond to compounds with molecular weights of 578.1 and 290.1 and
chemical formulae of C30H26O12 and C15H14O6 (578.142430 and 290.079040
amu respectively). There was an additional peak at m/z 867.2133 for the 75%
EtOH root extract (C). This protonated molecule may correspond to a
compound with a molecular weight of 866.2 and a possible chemical formula of
C45H38O18 (866.205820 amu). All three compounds matched putative structures
found in the Jodrell Laboratory reference library (Fig. 5.5) as condensed tannins
comprising an epicatechin (A), a procyanidin dimer type B (1, 2, 3, 4, 5, 6 or 8)
(B), and a procyanidin trimer type C1 (C). Structures and molecular weights for
these compounds were confirmed in the literature (Benavides et al., 2006;
Nunes et al., 2008; Takahashi et al., 1999).
The antimicrobial activity of condensed and hydrolysable tannins is well
reported with procyanidins having an intracellular action by inhibiting the αDNA
polymerase (Saito et al., 2005) and catechins, acting by damage to the
bacterial membrane (Cushnie and Lamb, 2005; Daglia, 2011). Procyanidins and
epicatechins in Theobroma cacao L. exhibited IC50 values of 12 µg/mL on lipid
peroxidation in rat liver microsomes and in a radical-scavenging DPPH assay
EC50 values of 6.2 µg/mL (Hatano, 2002). Epicatechins have demonstrated
analgesic properties; cyanidin found in tart cherries exhibited IC50 values of 60
µM compared to 1050 µM in aspirin (Harborne and Williams, 2000). A total of
27 condensed and hydrolysable tannins have been studied in the Potentilla
species with P. erecta demonstrating moderate antibacterial and antifungal
activities against S. aureus, E. coli and Candida albicans (Tomczyk and Latte,
2009).
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5.3.4.2 Compounds D and E
The same chromatograms for both extracts showed a base peak at m/z 489.4
(D) with an associated ion species at m/z 668.4 (Table 5.3). The protonated
[M+NH4]+ molecular ion at m/z 668.4371 may correspond to a molecular
formula of C36H58O10 (650.403000 amu) plus ammonia ion. The MS2 spectrum
showed a fragment ion pattern at m/z 489.1, 471.2 and 453.2 that matched a
structure (in-house reference library) for either tormentic acid glucosyl ester or a
tormentic acid glycoside + NH4 (Fig. 5.6). A β-D-glucopyranosyl ester of
tormentic acid has been isolated from a variety of plants including Rubus
glaucus Benth as well as Potentilla anserina L. and Potentilla erecta L. (Mertz et
al, 2007). Tormentic acid and its derivatives were recently reported to be
apoptotic, acting by inhibition of α and β-DNA polymerases in a range of human
tumour cell lines (Csuk et al., 2012; Tomczyk and Latte, 2009). Kite et al. (2007)
reported isobaric glycosyl esters of tormentic acid and euscaphic acids present
as major saponins of Potentilla tormentilla with compounds generating [2M-H]-
and [2M+CH3COO]- using negative ion electrospray. Saponins including ursolic
acid and euscaphic acid have been reported in some Potentilla species (Bilia, et
al., 1994; Wu et al., 2009; Tomczyk and Latte, 2009).
The full mass spectra of the 75% EtOH root extract in negative ion mode
showed a deprotonated molecular ion at m/z 301.05 (E) in Table 5.3. The MS2
spectrum displayed a major fragment ion at 257 and subsequent ions at 229,
201 and 185. This fragmentation pattern matched a potential structure in the in-
house library for ellagic acid that corresponds with a molecular formula of
C14H6O8 (302.006270 amu) shown with chemical structure in Appendix 5.2.
Fractions of EtOH root extract of Rubus ulmifolius Schott produced ellagic acid
and derivatives that inhibited S. aureus biofilm formation at 50 µg/mL and
increased antibiotic susceptibility to 15 clinical isolates of the same species and
in another study, four ellagic acid derivatives were found to inhibit growth of
yeast by damaging the cellular DNA (Quave et al., 2012; Xu et al., 2003).
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5.3.4.3 Compounds F and G
The HR-ESI-MS chromatogram for the root decoction in positive ion mode
showed a base peak at m/z 315.1 with major peaks at 477.1 (F) and 494.2 that
corresponded with [M+H]+ and [M+NH4]+ respectively (Table 5.3). These were
sodiated peaks giving a molecule with a potential molecular weight of 476.1 and
a molecular formula of C24H27O10 (476.168250 amu). A MS3 scan showed
fragmented ions at 297.1, 279.1, 207.0 and 188.9. By cross referencing the
molecular weight in the Dictionary of Natural Products database a putative
structure was located as agriminolide-6-O-glucopyranoside for the chemical
formula C24H28010 (Fig. 5.7). The negative ion high resolution mass spectra
show that this peak is not present in 75% EtOH root extract and may explain the
activity for the root decoction (Appendix 5.1). A survey of 43 naturally occurring
and synthetic coumarins demonstrated a wide range of activity against clinical
isolates of Gram-positive and Gram-negative bacteria from nearly 50%,
exhibiting no activity at 1000 µg/mL compared to 8-iodo-5,7-dihydroxycoumarin,
the drug of choice for MRSA infections (Smyth et al., 2009).
A prominent molecular peak at m/z 394.9 (G) in Table 5.3 corresponded
with [M-K]- giving a molecule with a possible molecular weight of 354,
consistent with chlorogenic acid plus potassium adduct (354.095085 amu).
Chlorogenic acid is known to exhibit antibacterial activity by increasing the
membrane permeability thereby disrupting cell wall synthesis (Wang et al.,
2013).
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5.4 Conclusion
Mapping the activity for each extract to the PCA loading plot followed the
methodology of Gao et al., (2010), whilst unknown peaks contributing to the
greatest variance were identified as targets responsible for the antimicrobial
activity (Watkins et al., 2012). The multivariate analysis was also used to direct
optimisation of the HPLC and develop a LC-MS method for the separation of
target compounds to determine chemical formulae and molecular mass. The
dilute plant extracts contained a high concentration of tannins, suggesting
nuclear magnetic resonance spectroscopy (NMR) would not be appropriate
prior to fractionating the compounds of interest and thus require collecting more
plant material. An alternative method would have been to use HPTLC-
densitometry; a method recently developed by Tomczyk et al. (2012), to
separate and quantify four quercetin derivatives in selected Potentilla species:
miquelianin, isoquercitrin, hyperoside and rutin, all known antimicrobial agents
and previously reported. However, with no access to this instrument, LC-MS
was chosen to separate target peaks and indentify putative compounds using
accurate mass cross referenced with chemical databases and spectral libraries.
Combination plant formulations are used in China as adjuvants in
orthodox treatments for lung cancer (Gao et al., 2010) and evidence is
gathering for using botanicals to assist in regaining susceptibility of antibiotics to
resistant pathogens (Savoia, 2012). The immunomodulating properties of P.
erecta, was shown to be an effective adjuvant in the treatment of HIV/TB
infected patients as part of a combination formula in an open label, Phase II
clinical trial (Nikolaeva et al., 2008). According to Tomczyk and Latte (2009),
Potentilla sericea L. is used as adjuvant as part of the orthodox medicinal
approach in treating cutaneous tuberculosis, suggesting that some of the
Potentilla genus may prove to be useful adjuvants in combating infection,
biofilm formation and reducing the amount of time for wounds to heal.
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By contrast, the P. reptans root extracts in our antimicrobial study were more
active than those reported for other Potentilla species (Tomczyk et al., 2007).
The HPLC peaks identified by the PCA analysis of the 75% EtOH root extracts
may contribute to the antimicrobial activity for example, tormentic acid, isolated
from Rosa rugosa, has been shown to have anti-inflammatory activity and
inhibit the production of nitric oxide in RAW26.4 cells (An et al., 2011) and has
also been reported for P. erecta (Table 5.1).
Two peaks that may account for the activity in P. reptans root decoction
suggested by the PCA analysis were the base peaks at m/z 609.1 and m/z
476.1 and not present in the 75%EtOH root extract. The root decoction showed
greatest inhibition of Gram-negative E. coli (MIC50 3.9 µg/mL) which may be
explained by the presence of the procyanidins (Daglia, 2011) or potentially, the
putative compound identified as agrimonolide-6-O-glucopyranoside. This
compound is a 3,4 dihydroisocoumarin glycoside recently isolated from
Agrimonia pilosa (Kato et al., 2010) and whilst coumarins have been reported
for a number of the Potentilla species including P. erecta (Sohretoglu and
Kirmizibekmez, 2011) this specific compound has not been reported for any of
the Potentilla species.
In the Anglo-Saxon formulations, P. reptans is specified as a decoction of
the whole plant and applied topically for burns and ulcerous sores, as a drink for
snakebite and to staunch bleeding (Table 2.7). These ancient indications are
similar to traditional uses of Potentilla species around the world. Clinical studies
have found extracts of P. erecta rhizome to be effective in the treatment of
ulcerative colitis (Huber et al., 2007) and in a randomised control trial, diarrhoea
due to a Rotavirus infection (Subbotina et al., 2003). In this study, the aqueous
and EtOH root extracts of P. reptans have shown to be appropriate for treating
bacterial infection of gram-positive and gram-negative pathogens commonly
associated with wounds.
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6.0 Conclusions
There have been a number of calls to research ancient medical literature
(Buenz et al., 2004; Holland, 1996; Riddle, 1974) but to date little has resulted
in scientific evaluation of the Anglo-Saxon herbal texts. Cameron (2006) argued
that at least two thirds of the formulations were pragmatic and medicinally
useful although he did not conduct any laboratory research. Brennessel et al.
(2005) reported poor antimicrobial activity for eleven Anglo-Saxon preparations
and as yet, the full experimental methods and data have not been published. To
date, this work described herein is the robust methodology used to determine
whether plants used in Anglo-Saxon formulations would have been fit for
purpose (Watkins et al., 2002).
The scope of work here is the first comprehensive study investigating the
historical and botanical context of three major Anglo-Saxon herbal texts in
conjunction with analysing the bioactivity and phytochemistry of the plants. The
research focus was native British plants used in treating bacterial infection and
wounds; an area that continues to be important to global health with the
increase of antibiotic resistance and the management of chronic conditions as
seen in diabetic leg ulcers. A systematic review of the 10th century Anglo-Saxon
herbal literature by Watkins et al., (2011) was the first contribution to scientific
knowledge for this project. The paper showed a medical system was present in
early medieval England ranging from the gold standard Leechbook compiled for
use by the royal physicians to short instructional texts for the lay practitioner
and simple monastic texts. Some of the plants would have been relevant for
treating the condition cited and worthy of further investigation to recover herbal
knowledge lost to Western herbal medicine.
Researching the 10th century herbal literature raised many issues
surrounding language, translation and context; the conditions and diseases
portrayed in the texts, identification of plants used and the manner in which the
formulations were prepared (Banham, 2002; Cameron, 2006; Van Arsdall,
2002). A number of historians have attempted to show the texts were of value
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with empathy on the part of the practitioner, pragmatic herbal preparations and
an overall intention that the patient should get well (Crawford, 2010; Meaney,
2002; Voigts, 1979). More than 130 plants referenced in the Anglo-Saxon
medical texts are listed in modern herbal pharmacopoeias (D’Aronco and
Cameron, 1998) with many of these plants still used in WHM (Barker, 2001;
Tobyn et al., 2011). This study contributes to the overall development of WHM
by informing the herbal profession of forgotten knowledge regarding medicinal
native species and the ancient practice of using topical and systemic herbal
formulae to treat wounds. To a Western herbal practitioner, the Anglo-Saxon
formulations could be considered stylistically similar to those found in
contemporary herbals with minimal preparatory instruction (Culpeper, 1654;
Grieve; 1931; Hoffman, 2002). Whilst looking at the layout of Bald’s Leechbook
and Lacnunga formulations, the author observed a number of repeated patterns
in the illuminated letters that await evaluation as to whether they are an integral
part of the formulation.
A key element of this project was the plant collection – firstly the logistics’
of obtaining permission from the Wildlife Trusts and private landowners to
harvest whole specimens from uninhabited locations and secondly, the
ethnobotanical approach of being sympathetic to the 10th century collection
methods. Quantities of plants harvested for each species were kept to a
minimum, meaning only analytical techniques that required micrograms as
opposed to grams of material were used. The screening and analytical
processes utilised <30 g of dried material of each species (Watkins et al.,
2012); a model that could be adopted by others to screen bioactivity of plants
referenced in historical texts.
Plant diversity changes with evolving agricultural methods and some
plants considered ubiquitous in the10th century are no longer abundant as seen
with B. officinalis. In the last 25 years, the plant has declined by nearly 50% in
southern England. Culpeper (1654) considered the dandelion to be so common
that it did not warrant a description which shows how herbal knowledge is easily
lost to future generations reading his herbal. Investigating the ethnobotanical
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use of medicinal plants and demonstrating bioactivity can help create
awareness of the importance in protecting species in decline. The medicinal use
of substitute plants used according to the local environment is seen with A.
minus, P. media and P. reptans and perhaps, one that medical herbalists
should reconsider to reduce the carbon footprint of herbal products when
replenishing their dispensary.
Plant mixtures contain thousands of compounds and whilst individual
metabolites can be identified as having antimicrobial activity in a pure form, the
true activity may be the result of a synergistic effect of multiple compounds
having one or more targets (Jalencas and Mestres, 2013; Williamson, 2001).
Complex plant mixtures are being used as adjuvants in orthodox treatment of
lung cancer in China (Gao et al., 2010) and there is evidence of plant
compounds being used to synergistically enhance antibiotic activity, whilst at
the same time reducing the amount of antibiotic given (Hancock, 2005).
Gibbons (2008) provides a convincing argument for plants as a source of
antimicrobial agents in that they produce metabolites as part of their chemical
defence; there is ethnobotanical evidence of plants being used topically and
systemically to treat antibacterial infection and there is chemical diversity in
plants and natural products.
In this study, all six plants exhibited IC50 values in one or more extracts
against Gram-positive microorganisms showing that all of the plants would have
provided some beneficial effect compared to a using plant exhibiting no activity.
The Betonica officinalis leaf extract was the most potent infusion against S.
aureus suggesting the plant may have wider applications than those applied in
current Western herbal practice. The P. reptans root decoction was the most
potent extract against E. coli in the antimicrobial screening. Further in vitro
studies showed this dilute extract to have activity against E. coli (MIC50 3.9
µg/mL) comparable to chloramphenicol, a broad spectrum antibiotic control, at
the lowest concentration. This suggests that the isolated compound could be
more potent, thus being of pharmaceutical interest (Gibbons, 2008). Relatively
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few plants inhibit growth of Gram-negative bacteria and potentially, once known,
the mechanism of the active compound in P. reptans may be of scientific
interest. Potentilla reptans may also possess other pharmacologically active
compounds beneficial to wound healing for example, anti-inflammatory and
tissue repair, reported for other Potentilla species (Tomcyzk and Latte, 2009).
A literature review of the phytochemistry for Potentilla species showed
only eight compounds (mainly flavonoids) reported for P. reptans leaves and to
date, nothing for the roots (Tomcyzk and Latte, 2009). With little reported
phytochemistry, the challenge here was that the active compounds were
unknown. By metabolomic mapping of the pharmacological activity onto the
chemical features, the PCA was used to discern different HPLC peaks between
the extracts of each species that may account for the antimicrobial activity. This
approach is relatively new to determine known markers within a complex plant
mixture (Bailey, 2004; Gao et al., 2010) and arguably, a novel approach for
unknown complex plant mixtures. For the first time, seven compounds were
putatively identified in P. reptans roots: caffeic acid, ellagic acid, ferulic acid,
chlorogenic acid, β-sitosterol, tormentic acid and agrimonolide-6-O-
glucopyranoside. The first five are ubiquitous in plants, known to have strong
antimicrobial activity and some already reported for P. reptans leaves (Fig. 5.1).
However, the latter two are of interest in that tormentic acid has been reported
for Potentilla species other than P. reptans and agrimonolide-6-O-
glucopyranoside, has not been reported for any Potentilla species. Derivatives
of agrimonolide have been reported for Agrimonia pilosa which is the same
family (Rosaceae) as Potentilla. If this compound is confirmed by NMR
spectroscopy, it will be the first report for P. reptans.
This study has laid the foundation for multidisciplinary research to
consider the early medieval literary heritage as a credible basis for systematic
investigation of pharmacologically active compounds and therapeutic
indications from native British plants, some of which are currently lost to
Western herbal medicine (Watkins et al., 2012).
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6.1 Specific Future Work
• Explore the hypothesis that there is a formulaic relationship between the
zoomorphic letters and the herbal formulations in the 10th century Anglo-
Saxon texts.
• Test the pure compounds available for those reported in P. reptans
decoction and 75% EtOH root extracts to determine MIC/MBC activity.
• Investigate the wound healing properties of P. reptans in anti-
inflammatory and tissue repair in vitro assays.
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Appendix 1.2 Herbaria sheet for P. reptans (voucher number FMW002 )
lodged at the herbarium, Royal Botanic Gardens, Kew for future reference.
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Plant Material 25%
EtOH
75%
EtOH
100%
Red Wine
Infusion or
Decoction
Leaves
A. eupatoria AGL25 AGL75 AGLW AGLINF
A. minus LBL25 LBL75 LBLW LBINF
B. officinalis BTL25 BTL75 BTLW BTINF
C. erythraea CTL25 CTL75 CTLW CTINF
P. media PTL25 PTL75 PTLW PTINF
P. reptans CIL25 CIL75 CILW CIINF
Roots
A. eupatoria AGR25 AGR75 AGRW AGDEC
A. minus LBR25 LBR75 LBRW LBDEC
B. officinalis BTR25 BTR75 BTRW BTDEC
C. erythraea CTR25 CTR75 CTRW CTDEC
P. media PTR25 PTR75 PTRW PTDEC
P. reptans CIR25 CIR75 CIRW CIDEC
Red Wine 2010 - - WO -
Red Wine 2011 - - WOW -
Appendix 2.1 Experimental codes assigned to leaf and root plant
extracts using EtOH, red wine and H2O. 
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Appendix 3.1 Confirmation letter from Health Protection Agency for E. coli strain
(UEL 57). Email correspondence from Marie Chattaway (20 December 2012)
confirmed serotyping as H49.
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Plant
Code
INF DEC 25% 75% Wine
Leaves
AGL 329 - 104 154 295
BTL 277 - 367 224 290
CIL 285 - 143 171 283
CTL 242 - 428 335 512
LBL 530 - 172 162 357
PTL 306 - 256 224 187
Roots
AGR - 267 209 236 682
BTR - 544 325 403 544
CIR - 1232 199 232 769
CTR - 61 - 42 510
LBR - 313 118 152 682
PTR - 262 168 197 434
WO1 - - - - 668
WO2 - - - - 542
Appendix 3.2 Dried yield (mg) from 2 g of A. eupatoria, B.
officinalis, P. reptans, C. erythraea, P. media and A. minus leaf and
root extracts and red wine controls stored at 4 °C. 
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Appendix 3.3 S. aureus antimicrobial screening results for leaf extracts (from left to
right) at 200, 40 and 8 µg/mL. Key: Inf Leaves in boiling H2O; LW Red Wine; L25 25%
EtOH; L75 75% EtOH and CHL Chloramphenicol (positive control). * denotes
significant inhibition (p <0.05).
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Appendix 3.4 B. subtilis antimicrobial screening results for leaf extracts (from left to
right) at 200, 40 and 8 µg/mL. Key: Inf Leaves in boiling H2O; LW Red wine; L25 25%
EtOH; L75 75% EtOH and CHL Chloramphenicol (positive control).
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Appendix 3.5 E. coli antimicrobial screening results for leaf extracts (from left to right)
at 200, 40 and 8 µg/mL. Key: Inf Leaves in boiling H2O; LW Red wine; L25 25% EtOH;
L75 75% EtOH and CHL Chloramphenicol (positive control).
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Appendix 3.6 P. aeruginosa antimicrobial screening results for leaf extracts (from left
to right) at 200, 40 and 8 µg/mL. Key: Inf Leaves in boiling H2O; LW Red wine; L25
25% EtOH; L75 75% EtOH and CHL Chloramphenicol (positive control).  
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Appendix 3.7 B. subtilis antimicrobial screening results for root extracts (from left to
right) at 200, 40 and 8 µg/mL. Key: Dec Roots in boiling H2O; RW Red wine; R25 25%
EtOH; R75 75% EtOH and CHL Chloramphenicol (positive control).
* denotes significant inhibition (p <0.05).
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Appendix 3.8 P. aeruginosa antimicrobial screening results for root extracts (from left
to right) at 200, 40 and 8 µg/mL. Key: Dec Roots in boiling H2O; RW Red wine; R25
25% EtOH; R75 75% EtOH and CHL Chloramphenicol (positive control).
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Appendix 6.1 Review of plants used in 10th century Anglo-Saxon
formulations published in Drug Discovery Today.
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Appendix 6.2 Paper titled ‘Antimicrobial assays of three native British plants used
in 10th century Anglo-Saxon medicine for wound healing formulations in 10th century
England’, published in the Journal of Ethnopharmacology.
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Appendix 6.3 Frances Watkins’ Declaration 31 May 2013.
